<SEC-DOCUMENT>0001213900-21-063775.txt : 20211207
<SEC-HEADER>0001213900-21-063775.hdr.sgml : 20211207
<ACCEPTANCE-DATETIME>20211207064145
ACCESSION NUMBER:		0001213900-21-063775
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20211201
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211207
DATE AS OF CHANGE:		20211207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aditxt, Inc.
		CENTRAL INDEX KEY:			0001726711
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823204328
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39336
		FILM NUMBER:		211474648

	BUSINESS ADDRESS:	
		STREET 1:		737 N. FIFTH STREET, SUITE 200
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23219
		BUSINESS PHONE:		909-488-0844

	MAIL ADDRESS:	
		STREET 1:		737 N. FIFTH STREET, SUITE 200
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aditx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20201113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADiTx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20171229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea151838-8k_aditxtinc.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ADTX="http://aditxt.com/20211201">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_ADTX_aditxt.com_20211201 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20211201_20211201 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001726711 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityCentralIndexKey">0001726711</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="adtx-20211201.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-12-01to2021-12-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001726711</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90B_edei--DocumentType_c20211201__20211201_zE6sfiz5AZ41"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_903_edei--DocumentPeriodEndDate_c20211201__20211201_z1XCLkKZup38"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 1, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20211201__20211201_zifPzSH6jvXb"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityRegistrantName">Aditxt, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20211201__20211201_z1dqpMIFE1M6"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="padding: 0.25pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_90D_edei--EntityFileNumber_c20211201__20211201_zQ8JI9uNDzP"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityFileNumber">001-39336</ix:nonNumeric></span></b></td>
    <td style="padding: 0.25pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20211201__20211201_zSzSBrgkwlTf"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityTaxIdentificationNumber">82-3204328</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(State or other jurisdiction</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">of incorporation)</p></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top; font-size: 10pt; text-align: center">(Commission File Number)</td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; font-size: 10pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(IRS Employer</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 49%; font-size: 10pt; text-align: center"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20211201__20211201_z3qE4kXEyeZi"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityAddressAddressLine1">737 N. Fifth Street</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20211201__20211201_zUohNkoGou01"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressCityOrTown_c20211201__20211201_zLEXgUMMb39l"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityAddressCityOrTown">Richmond</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20211201__20211201_zSEAQw01Msm5"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityAddressStateOrProvince">VA</ix:nonNumeric></span></b></td>
    <td style="padding: 0.25pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 49%; font-size: 10pt; text-align: center"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20211201__20211201_zlmne30TqSP1"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:EntityAddressPostalZipCode">23219</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center">(Address of principal executive offices)</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b><span id="xdx_909_edei--CityAreaCode_c20211201__20211201_zcd49NlnGHKe"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:CityAreaCode">(650)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20211201__20211201_z6GAm5PQFER"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:LocalPhoneNumber">870-1200</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i>
General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--WrittenCommunications_c20211201__20211201_zNPhqKQlrve6"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--SolicitingMaterial_c20211201__20211201_zlgbO98UwLr4"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--PreCommencementTenderOffer_c20211201__20211201_zgF3gTBbkjh2"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20211201__20211201_zzbfBLlhWIc4"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 32%; font-size: 10pt; text-align: center"><b>Title of each class</b></td>
    <td style="padding: 0.25pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 32%; font-size: 10pt; text-align: center"><b>Trading Symbol(s)</b></td>
    <td style="padding: 0.25pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; width: 32%; font-size: 10pt; text-align: center"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20211201__20211201_z5zJdWtd8Kxe"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:Security12bTitle">Common Stock, par value $0.001</ix:nonNumeric></span></td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center"><span id="xdx_90F_edei--TradingSymbol_c20211201__20211201_zVTjMLrZ4prb"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" name="dei:TradingSymbol">ADTX</ix:nonNumeric></span></td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center">The <span id="xdx_902_edei--SecurityExchangeName_c20211201__20211201_zDKt3nJkWqv"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20211201__20211201_zrC1vaPREYwi"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityExTransitionPeriod_c20211201__20211201_zvce0xupTeS6"><ix:nonNumeric contextRef="From2021-12-01to2021-12-01" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
December 1, 2021, Aditxt, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;)
with Dawson James Securities, Inc., as representative of the several underwriters identified therein (the &#8220;Underwriters&#8221;),
relating to the public offering (the &#8220;Offering&#8221;) by the Company of 16,575,000 units (the &#8220;Units&#8221;), with each unit
comprised of one share of the Company&#8217;s common stock (the &#8220;Shares&#8221;) and one Series C warrant to purchase one Share at
an exercise price of $1.15 per share (the &#8220;Series C Warrants&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company also offered to those purchasers, if any, whose purchase of common stock in the Offering would otherwise result in such purchaser,
together with its affiliates and certain related parties, beneficially owning more than 4.99% of the Company&#8217;s outstanding common
stock immediately following the consummation of the Offering, the opportunity, in lieu of purchasing Units, to purchase pre-funded warrants,
(the &#8220;Pre-Funded Units&#8221;). Each Pre-Funded Warrant was offered and sold together with the same Series C Warrants described
above being sold with each share of common stock. For each Pre-Funded Unit purchased in the Offering in lieu of Units, the Company reduced
the number of Units being sold in the Offering on a one-for-one basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Units were offered, issued and sold at a price to the public of $1.05 per share under a prospectus supplement and accompanying prospectus
filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) pursuant to an&#160;effective shelf registration statement filed
with the SEC on</span>&#160;Form S-3 (File No. 333-257645), which was declared effective by the SEC on July 13, 2021. The Company may
loan up to <span style="background-color: white">$5,315,500 of the proceeds from the offering to AiPharma Global Holdings LLC (&#8220;AiPharma
Global&#8221;), pursuant to the terms of the Company&#8217;s credit agreement with AiPharma Global, as amended. As a result, the amount
that would be outstanding under the credit agreement, as amended, following such loan would be $14,500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Underwriting Agreement contained customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act, other obligations
of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were
made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and were
subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Underwriting Agreement and Series C Warrant Agreement (including the form of Series C Warrant) are filed as Exhibits 1.1 and 10.1, respectively,
hereto and are incorporated herein by reference. The foregoing descriptions of the terms of the Underwriting Agreement and Series C Warrant
are qualified in their entirety by reference to such exhibits. A copy of the opinion of Sheppard, Mullin, Richter &amp; Hampton LLP relating
to the legality of the issuance and sale of the Shares in the Offering is attached as Exhibit 5.1 hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">On
December 6, 2021, the Company closed the Offering of the Units at a price to the public of $1.05 per Unit for net proceeds of approximately
$16.2 million, after deducting the underwriting discount. The Shares are listed on The NASDAQ Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statement and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><b>(d)</b></td><td style="text-align: justify"><b>Exhibits:</b></td>
</tr></table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><b>Exhibit&#160;No.</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%"><b>Description</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>1.1</b></td>
    <td>&#160;</td>
    <td><a href="ea151838ex1-1_aditxtinc.htm">Underwriting Agreement between the Company and Dawson James Securities, Inc., dated December 1, 2021.</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>5.1</b></td>
    <td>&#160;</td>
    <td><a href="ea151838ex5-1_aditxtinc.htm">Sheppard, Mullin, Richter &amp; Hampton LLP Legal Opinion.</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>23.1</b></td>
    <td>&#160;</td>
    <td><a href="ea151838ex5-1_aditxtinc.htm">Consent of Sheppard, Mullin, Richter &amp; Hampton LLP (included in Exhibit 5.1)</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>99.1</b></td>
    <td>&#160;</td>
    <td><a href="ea151838ex99-1_aditxtinc.htm">Press release dated December 6, 2021</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>104</b></td>
    <td>&#160;</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt"><b>ADITXT, INC.</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; width: 60%">&#160;</td>
    <td style="padding: 0.25pt; width: 4%">&#160;</td>
    <td style="padding: 0.25pt; width: 36%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; font-size: 10pt">Date: December 7, 2021</td>
    <td style="padding: 0.25pt; font-size: 10pt">By:</td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt">/s/ Corinne Pankovcin</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt">Corinne Pankovcin</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt">President</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">-2-</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZS00KdtGlRUWsUoqI22CnEmwzZRKrHslbGlvEYWAY/n//CzETG1qbFhnOy6qAI3Z9qz1ChQ0y2gsGR77dZRBuhVfjPGvrx/cH5hQYDMwiVvIShNE6GId1BiqZy3SeKJBpphZQ7kX01XOyjanReqNb0LaGkqlng17za0o46idZ6l5j1QnZGbIhLpaT/IZEqgQONOgH8c1BUeQimo0TiQ3Tvf/W3J2nDlYtdqHLTeh/ow8WbElH -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea151838ex1-1_aditxtinc.htm
<DESCRIPTION>UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND DAWSON JAMES SECURITIES, INC., DATED DECEMBER 1, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>UNDERWRITING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">December 1, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dawson James Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As Representative of the Several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 North Federal Highway &ndash; 5th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boca Raton, FL 33432</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, Aditxt, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), hereby confirms its agreement (this &ldquo;<U>Agreement</U>&rdquo;) with Dawson
James Securities, Inc. (the &ldquo;<U>Representative</U>&rdquo;) and with the other underwriters, if any, named on <U>Schedule 1</U> hereto
for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the
&ldquo;<U>Underwriters</U>&rdquo; or, individually, an &ldquo;<U>Underwriter</U>&rdquo;) as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">1. <U>Purchase
and Sale of Shares and Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Firm
Shares and Firm Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Nature
and Purchase of Firm Shares and Firm Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(A) On
the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company
agrees to issue and sell to the Underwriters an aggregate of 16,575,000 units (each a &ldquo;<U>Unit</U>,&rdquo; and collectively, the
&ldquo;<U>Units</U>&rdquo;), each comprised of one share (the &ldquo;<U>Firm Shares</U>&rdquo;) of Company common stock, par value $0.001
per share (the &ldquo;<U>Common Shares</U>&rdquo;), and (ii) a Series C warrant to purchase one Common Share at an exercise price of $1.15
per share (the &ldquo;<U>Firm Warrants</U>&rdquo; and, collectively with the Firm Shares, the &ldquo;<U>Firm Securities</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(B) The
Underwriters, severally and not jointly, agree to purchase from the Company the number of Units set forth opposite their respective names
on <U>Schedule 1</U> attached hereto and made a part hereof. The combined purchase price for one Unit shall be $0.9765 (93% of the public
offering price per Unit of $1.05) or $0.9665 for Units consisting of a Pre-Funded Warrant and a Warrant which shall be allocated as $0.9673
per Firm Share and/or Pre-Funded Warrant (the &ldquo;<U>Share Purchase Price</U>&rdquo;) and $0.0092 per Firm Warrant (the &ldquo;<U>Warrant
Purchase Price</U>&rdquo;). The Units are to be offered initially to the public at the offering price set forth on the cover page of the
Prospectus (as defined in Section 2(a)(B) hereof) (the &ldquo;<U>Purchase Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(C) To the
extent that the purchase of Firm Shares would cause the beneficial ownership of a purchaser in the Offering, together with its affiliates
and certain related parties, to exceed 4.99% of the shares of Common Stock, the Company agrees to issue the Underwriters, for delivery
to such purchasers, at the election of the purchasers, a number of Pre-Funded Warrants (the &ldquo;Pre-Funded Warrants&rdquo;), which
are initially convertible on a 1-for-1 basis into shares of Common Stock, at an exercise price of $0.001 in lieu of the Firm Shares. The
Firm Shares or the Pre-Funded Warrants, as applicable, and the Firm Warrants, as well as the Common Stock issuable upon exercise of the
Warrants (the &ldquo;Warrant Shares&rdquo;) are hereinafter referred to together as the &ldquo;Firm Securities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Securities
Payment and Delivery</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(A) Delivery
and payment for the Units shall be made no later than to 4:00 p.m., Eastern time, on the second (2<SUP>nd</SUP>) Business Day following
the effective date (the &ldquo;<U>Effective Date</U>&rdquo;) of the Registration Statement (as defined in Section 2(a)(i)(A) below) (or
the third (3<SUP>rd</SUP>) Business Day following the Effective Date if the Registration Statement is declared effective after 4:01 p.m.,
Eastern time) or at such other time as shall be agreed upon by the Representative and the Company, at the offices of Schiff Hardin LLP,
901 K Street NW, Suite 700, Washington DC 20001 (&ldquo;<U>Representative&rsquo;s Counsel</U>&rdquo;), or at such other place (or by electronic
transmission) as shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment for the Units is
called the &ldquo;<U>Closing Date</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(B) Payment
for the Units shall be made on the Closing Date by wire transfer in federal (same day) funds, payable to the order of the Company upon
delivery of the Units (in form and substance satisfactory to the Underwriters), for the account of the Underwriters. The Firm Shares and
Firm Warrants underlying the Units shall be registered in such name or names and in such authorized denominations as the Representative
may request in writing prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Shares and Firm Warrants
underlying the Units except upon tender of payment by the Representative for all of the Units or via delivery versus payment for the Units.
The term &ldquo;<U>Business Day</U>&rdquo; means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking
institutions are authorized or obligated by law to close in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Over-Allotment
Option</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Option
Securities</U>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Units, the Company
hereby grants to the Representative an option (the &ldquo;<U>Over-Allotment Option</U>&rdquo;) to purchase, in the aggregate, (a) up to
2,486,250 additional Common Shares (15% of the Firm Shares) at a purchase price per share of $0.9673 (93% of the public offering price
allocated to each Firm Share) (the &ldquo;<U>Option Shares</U>&rdquo; and together with the Firm Shares, the &ldquo;<U>Shares</U>&rdquo;),
and/or (b) warrants to purchase an aggregate of 2,486,250 Common Shares (15% of the Firm Warrants) at a purchase price of $0.0092 per
warrant (93% of the public offering price allocated to each Firm Warrant) (the &ldquo;<U>Option Warrants</U>&rdquo; and together with
the Firm Warrants, the &ldquo;<U>Warrants</U>&rdquo;), which may be purchased in any combination of Option Shares and/or the Option Warrants.
The Option Shares and the Option Warrants are referred to as the &ldquo;<U>Option Securities</U>&rdquo;). The Firm Securities and the
Option Securities are collectively referred to as the &ldquo;<U>Public Securities</U>.&rdquo; The Public Securities shall be issued directly
by the Company and shall have the rights and privileges described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus referred to below. The offering and sale of the Public Securities is hereinafter referred to as the &ldquo;<U>Offering</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Exercise
of Over-Allotment Option</U>. The Over-Allotment Option granted pursuant to Section 1(b)(i) hereof may be exercised by the Representative
as to all (at any time) or any part (from time to time) of the Option Securities within 45 days after the Closing Date. An Underwriter
shall not be under any obligation to purchase any Option Securities prior to the exercise of the Over-Allotment Option by the Representative.
The Over-Allotment Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must
be confirmed in writing by overnight mail or by email or other electronic transmission setting forth the number of Option Shares and/or
Option Warrants to be purchased and the date and time for delivery of and payment for the Option Shares and/or Option Warrants, as the
case may be (each, an &ldquo;<U>Option Closing Date</U>&rdquo;), which shall not be earlier than one (1) Business Day nor later than five
(5) full Business Days after the date of the written notice or such other time as shall be agreed upon by the Company and the Representative,
at the offices of the Representative&rsquo;s Counsel, or at such other place (including remotely by electronic transmission) as shall
be agreed upon by the Company and the Representative. If such delivery and payment for the Option Shares and/or Option Warrants does not
occur on the Closing Date, each Option Closing Date will be as set forth in the notice. Upon exercise of the Over-Allotment Option, the
Company will become obligated to convey to the Representative, and, subject to the terms and conditions set forth herein, the Representative
will become obligated to purchase, the number of Option Shares and/or Option Warrants specified in such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Payment
and Delivery</U>. Payment for the Option Shares and/or Option Warrants shall be made on the Option Closing Date by wire transfer in federal
(same day) funds, payable to the order of the Company upon delivery to the Representative of certificates (in form and substance satisfactory
to the Representative) representing the Option Shares and/or Option Warrants (or through the facilities of the Depositary Trust Company
or Deposit/Withdrawal at Custodian transfer) for the account of the Representative. The Option Shares and/or Option Warrants shall be
registered in such name or names and in such authorized denominations as the Representative may request in writing prior to the Option
Closing Date. The Company shall not be obligated to sell or deliver the Option Shares and/or Option Warrants except upon tender of payment
by the Representative for the applicable Option Shares and/or Option Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Representative&rsquo;s
Unit Purchase Option</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Representative&rsquo;s
Unit Purchase Option</U>. The Company hereby agrees to issue to the Representative (and /or its designees) on the Closing Date a unit
purchase option for the purchase of the number of Units equal to 5.0% of the number of Units issued in the Offering, pursuant to a unit
purchase option agreement in the form attached hereto as Exhibit A (the &ldquo;<U>Representative&rsquo;s Unit Purchase Option</U>&rdquo;),
at an initial exercise price of $1.3125 per Unit, which is equal to 125% of the public offering price for one Unit. The Representative&rsquo;s
Unit Purchase Option and the Warrants and Common Shares, including the Common Shares issuable upon exercise of the Warrants included in
the Representative&rsquo;s Unit Purchase Option are hereinafter referred to together as the &ldquo;<U>Representative&rsquo;s Securities</U>.&rdquo;
The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the
Representative&rsquo;s Unit Purchase Option and the underlying securities during the 180 days after the Effective Date and by its acceptance
thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representative&rsquo;s Unit Purchase Option, or
any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective
economic disposition of such securities for a period of 180 days following the Effective Date to anyone other than (i) an Underwriter
or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such Underwriter
or selected dealer; or as otherwise expressly permitted by FINRA Rule 5110(g), and only if any such transferee agrees to the foregoing
lock-up restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Delivery</U>.
Delivery of the Representative&rsquo;s Unit Purchase Option shall be made on the Closing Date, and shall be issued in the name or names
and in such authorized denominations as the Representative may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2. <U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as of the Applicable Time (as defined below)
and as of the Closing Date, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Registration
Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Pursuant
to the Securities Act</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">(A) The
Company has filed with the Commission a registration statement on Form S-3 (File No. 333-257645) including a related prospectus, for the
registration of certain securities (the &ldquo;<U>Shelf Securities</U>&rdquo;), including the Public Securities and the Representative&rsquo;s
Securities, under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) and the rules and regulations thereunder
(the &ldquo;<U>Securities Act Regulations</U>&rdquo;). The registration statement has been declared effective under the Securities Act
by the Commission. As of any time, such registration statement as amended by any post-effective amendments thereto to such time, including
the exhibits and any schedules thereto at such time, the documents incorporated or deemed to be incorporated by reference therein at such
time pursuant to Form S-3 under the Securities Act and the documents otherwise deemed to be a part thereof as of such time pursuant to
Rule 430A (&ldquo;<U>Rule 430A</U>&rdquo;) or Rule 430B under the Securities Act Regulations (&ldquo;<U>Rule 430B</U>&rdquo;), is referred
to herein as the &ldquo;<U>Registration Statement</U>;&rdquo; provided, however, that the &ldquo;Registration Statement&rdquo; without
reference to a time means such registration statement as amended by any post-effective amendments thereto as of the time of the first
contract of sale for the Public Securities, which time shall be considered the &quot;new effective date&quot; of such registration statement
with respect to the Public Securities within the meaning of paragraph (f)(2) of Rule 430B, including the exhibits and schedules thereto
as of such time, the documents incorporated or deemed incorporated by reference therein at such time pursuant to Form S-3 under the Securities
Act and the documents otherwise deemed to be a part thereof as of such time pursuant to the Rule 430A or Rule 430B. Any registration statement
filed pursuant to Rule 462(b) of the Securities Act Regulations is hereinafter called the &ldquo;<U>Rule 462(b) Registration Statement</U>,&rdquo;
and after such filing the term &ldquo;Registration Statement&rdquo; shall include the 462(b) Registration Statement. The prospectus covering
the Shelf Securities, included in the Form S-3 filed September 21, 2017, is hereinafter referred to as the &ldquo;<U>Base Prospectus</U>.&rdquo;
The Base Prospectus, as supplemented by the prospectus supplement specifically related to the Public Securities in the form first used
to confirm sales of the Public Securities (or in the form first made available to the Underwriter by the Company to meet requests of purchasers
pursuant to Rule 173 under the Securities Act), is hereinafter referred to, collectively, as the &ldquo;<U>Prospectus</U>,&rdquo; and
the term &ldquo;<U>Preliminary Prospectus</U>&rdquo; means any preliminary form of the Prospectus, including any preliminary prospectus
supplement specifically related to the Public Securities, filed with the Commission by the Company with the consent of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">(B) All
references in this Agreement to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included&rdquo;
or &ldquo;stated&rdquo; (or other references of like import) in the Registration Statement, any Preliminary Prospectus or the Prospectus
shall be deemed to include all such financial statements and schedules and other information incorporated or deemed incorporated by reference
in the Registration Statement, such Preliminary Prospectus or the Prospectus, as the case may be, prior to the execution and delivery
of this Agreement; and all references in this Agreement to amendments or supplements to the Registration Statement, any Preliminary Prospectus
or the Prospectus shall be deemed to include the filing of any document under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;), and the rules and regulations thereunder (the &ldquo;<U>Exchange Act Regulations</U>&rdquo;), incorporated or deemed
to be incorporated by reference in the Registration Statement, such Preliminary Prospectus or the Prospectus, as the case may be, at or
after the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">(C) The
term &ldquo;<U>Pricing Disclosure Package</U>&rdquo; means (i) the Preliminary Prospectus, as most recently amended or supplemented immediately
prior to the Applicable Time (as defined herein), and (ii) the information included on Schedule 2 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in">(D) &ldquo;<U>Applicable
Time</U>&rdquo; means [&#9679;], Eastern time, on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Stock
Exchange Listing</U>. The Common Shares are approved for listing on The Nasdaq Capital Market (the &ldquo;<U>Exchange</U>&rdquo;), subject
to official notice of issuance, and the Company has taken no action designed to, or likely to have the effect of, delisting the Common
Shares from the Exchange, nor has the Company received any notification that the Exchange is contemplating terminating such listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>No
Stop Orders, etc</U>. Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued any order
preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted or, to
the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied with each
request (if any) from the Commission for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Organization;
Good Standing; No Subsidiaries</U>. The Company has been duly incorporated and is validly existing as entities in good standing under
the laws of the State of Delaware, with power and authority to own, lease and operate its respective properties and conduct its respective
businesses as described in the Preliminary Prospectus, and has been duly qualified as foreign corporations for the transaction of business
and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as
to require such qualification, except where the failure so to qualify or be in good standing would not have a Material Adverse Change
(as defined in Section 2(f)(i)). The Company is not in violation or default of any of the provisions of its certificate of incorporation,
bylaws or other organizational or charter documents. The Company does not have any direct or indirect subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Disclosures
in Registration Statement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Compliance
with Securities Act and 10b-5 Representation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(A) Each
of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material respects
with the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus, including the prospectus
filed as part of the Registration Statement as originally filed or as part of any amendment or supplement thereto, and the Prospectus,
at the time each was filed with the Commission, complied in all material respects with the requirements of the Securities Act and the
Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection with this Offering and the
Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except
to the extent permitted by Regulation S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(B) Neither
the Registration Statement nor any amendment thereto, at its respective effective time, contained, contains or will contain an untrue
statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading; provided, however, that this representation and warranty shall not apply to the&nbsp;Underwriters&rsquo;
Information (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(C) The
Pricing Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date, did not, does not, and will
not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty
shall not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished to the
Company with respect to the Underwriters by the Representative expressly for use in the Registration Statement, the Preliminary Prospectus
or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided by
or on behalf of any Underwriter consists solely of the following disclosure contained in the following paragraphs in the &ldquo;Underwriting&rdquo;
section of the Prospectus: (i) the names of the several underwriters, and (ii) the information under the subsections &ldquo;Discounts,
Commissions and Expenses&rdquo;; and &ldquo;Electronic Distribution&rdquo; (the &ldquo;<U>Underwriters&rsquo; Information</U>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(D) Neither
the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of any filing
with the Commission pursuant to Rule 424(b), or at the Closing Date, included, includes or will include an untrue statement of a material
fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to the&nbsp;Underwriters&rsquo;
Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Disclosure
of Agreements</U>. The agreements and documents described in the Registration Statement, the Pricing Disclosure Package and the Prospectus
conform in all material respects to the descriptions thereof contained therein and there are no agreements or other documents required
by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed.
Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound
or affected and (i)&nbsp;that is referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and (ii)&nbsp;is
material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is in full force and effect in
all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance
with its terms, except (w) for such agreements or instruments for enforceability of which would not reasonably be expected to result,
individually or in the aggregate, in a Material Adverse Change, (x)&nbsp;as such enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors&rsquo; rights generally, (y)&nbsp;as enforceability of any indemnification or contribution
provision may be limited under the federal and state securities laws, and (z)&nbsp;that the remedy of specific performance and injunctive
and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, none of
such agreements or instruments has been assigned by the Company, and neither the Company nor, to the Company&rsquo;s knowledge, any other
party is in material default thereunder and, to the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the
giving of notice, or both, would constitute a material default thereunder, except as disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, or which would not reasonably be expected to result, individually or in the aggregate, in a Material
Adverse Change. To the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements or instruments
will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency
or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a &ldquo;<U>Governmental
Entity</U>&rdquo;), including, without limitation, those relating to environmental laws and regulations, except such violations which
would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Prior
Securities Transactions</U>. Since the beginning of the last two full fiscal years, no securities of the Company have been sold by the
Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by or under common control with the
Company, except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Preliminary Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) <U>Regulations</U>.
The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning the effects of federal, state,
local and foreign laws, rules and regulations relating to the Company&rsquo;s business as currently contemplated are correct in all material
respects and no other such regulations are required to be disclosed in the Registration Statement, the Pricing Disclosure Package and
the Prospectus which are not so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Changes
After Dates in Registration Statement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>No
Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, except as otherwise specifically stated therein: (i)&nbsp;there has been no material adverse change in the
financial position or results of operations of the Company, nor, to the Company&rsquo;s knowledge, any change or development that, singularly
or in the aggregate, would involve a material adverse change in or affecting the condition (financial or otherwise), results of operations,
business or assets of the Company, taken as a whole (a &ldquo;<U>Material Adverse Change</U>&rdquo;); (ii)&nbsp;there have been no material
transactions entered into by the Company, other than as contemplated pursuant to this Agreement; and (iii)&nbsp;no officer or director
of the Company has resigned from any position with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Recent
Securities Transactions, etc</U>. Subsequent to the respective dates as of which information is given in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i)&nbsp;issued any securities (other than (i) grants
under any stock compensation plan and (ii) Common Shares issued upon exercise or conversion of option, warrants or convertible securities
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus) or incurred any liability or obligation, direct
or contingent, for borrowed money; or (ii)&nbsp;declared or paid any dividend or made any other distribution on or in respect to its capital
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Independent
Accountants</U>. To the knowledge of the Company, dbb<I>mckennon</I>, during such time as it was engaged by the Company (the &ldquo;<U>Auditors</U>&rdquo;),
has been and is an independent registered public accounting firm as required by the Securities Act and the Securities Act Regulations
and the Public Company Accounting Oversight Board. During such time period in which the Auditors served as the Company&rsquo;s independent
registered public accounting firm, the Auditors did not or have not, during the periods covered by the financial statements included in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, provided to the Company any non-audit services, as such
term is used in Section 10A(g) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>SEC
Reports; Financial Statements, etc</U>. The Company has complied in all material respects with requirements to file all reports, schedules,
forms, statements and other documents required to be filed by it under the Securities Act and the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof (the foregoing materials, as amended, including the exhibits thereto and documents incorporated by reference
therein, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates,
the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations
of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in
all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as
in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified
in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required
by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments. The financial statements, including the notes thereto and supporting schedules included
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, fairly present in all material respects the financial
position and the results of operations of the Company at the dates and for the periods to which they apply; and such financial statements
have been prepared in conformity with GAAP, consistently applied throughout the periods involved (provided that unaudited interim financial
statements are subject to year-end audit adjustments that are not expected to be material in the aggregate and do not contain all footnotes
required by GAAP); and the supporting schedules included in the Registration Statement present fairly in all material respects the information
required to be stated therein. Except as included therein, no historical or pro forma financial statements are required to be included
in the Registration Statement, the Pricing Disclosure Package or the Prospectus under the Securities Act or the Securities Act Regulations.
The pro forma and pro forma as adjusted financial information and the related notes, if any, included in the Registration Statement, the
Pricing Disclosure Package and the Prospectus have been properly compiled and prepared in all material respects in accordance with the
applicable requirements of the Securities Act and the Securities Act Regulations and present fairly in all material respects the information
shown therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are appropriate to
give effect to the transactions and circumstances referred to therein. All disclosures contained in the Registration Statement, the Pricing
Disclosure Package or the Prospectus regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules and regulations
of the Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent
applicable. Each of the Registration Statement, the Pricing Disclosure Package and the Prospectus discloses all material off-balance sheet
transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company with unconsolidated
entities or other persons that may have a material current or future effect on the Company&rsquo;s financial condition, changes in financial
condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses.
Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (a) the Company has not incurred
any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course
of business, (b) the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock,
(c) there has not been any change in the capital stock of the Company (other than (i) grants under any stock compensation plan and (ii)
Common Shares issued upon exercise or conversion of option, warrants or convertible securities described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus), and (d) there has not been any Material Adverse Change in the Company&rsquo;s long-term
or short-term debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Authorized
Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions stated in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will have on the Closing Date the adjusted
stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Pricing Disclosure
Package and the Prospectus, on the Effective Date, as of the Applicable Time, and on the Closing Date, there will be no stock options,
warrants, or other rights to purchase or otherwise acquire any authorized, but unissued Common Shares or any security convertible or exercisable
into Common Shares, or any contracts or commitments to issue or sell Common Shares or any such options, warrants, rights or convertible
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Valid
Issuance of Securities, etc.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Outstanding
Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have
been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission with respect
thereto, and are not subject to personal liability by reason of being such holders; and none of such securities were issued in violation
of the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. The offers
and sales of the outstanding Common Shares were at all relevant times either registered under the Securities Act and the applicable state
securities or &ldquo;blue sky&rdquo; laws or, based in part on the representations and warranties of the purchasers of such shares, exempt
from such registration requirements. The authorized Common Shares and other outstanding securities conform in all material respects to
all statements relating thereto contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Securities
Sold Pursuant to this Agreement</U>. The Public Securities and the Representative&rsquo;s Securities have been duly authorized for issuance
and sale and, when issued and paid for in accordance with the terms of this Agreement, will be validly issued, fully paid and non-assessable;
the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Public Securities and Representative&rsquo;s
Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual
rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities
and Representative&rsquo;s Securities has been duly and validly taken. The Public Securities and Representative&rsquo;s Securities conform
in all material respects to all statements with respect thereto contained in the Registration Statement, the Pricing Disclosure Package
and the Prospectus. The Common Shares issuable upon exercise of the Warrants and the Representative&rsquo;s Unit Purchase Option (including
the Warrants underlying the Representative&rsquo;s Unit Purchase Option) (the &ldquo;<U>Underlying Common Stock</U>&rdquo;) have been
duly authorized and reserved for issuance by all necessary corporate action on the part of the Company and when paid for and issued in
accordance with such Warrants or the Representative&rsquo;s Unit Purchase Option (including the Warrants underlying the Representative&rsquo;s
Unit Purchase Option), or exercised on a cashless basis as set forth in such warrants or Representative&rsquo;s Unit Purchase Option,
if applicable, as the case may be, such shares of Underlying Common Stock will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Registration
Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no
holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have
the right to require the Company to register any such securities of the Company under the Securities Act or to include any such securities
in a registration statement to be filed by the Company (except for any such rights that have been waived or with respect to securities
covered by any effective registration statement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Validity
and Binding Effect of Agreements</U>. This Agreement, the Warrant Agreement by and between the Company and VStock Transfer, LLC (the &ldquo;<U>Warrant
Agreement</U>&rdquo;), and the Representative&rsquo;s Unit Purchase Option have been duly and validly authorized by the Company and, when
executed and delivered, will constitute, the valid and binding agreements of the Company, enforceable against the Company in accordance
with their respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization, fraudulent conveyance,
fraudulent transfer, moratorium or similar laws affecting creditors&rsquo; rights generally; (ii) as enforceability of any indemnification
or contribution provision may be limited under the federal and state securities laws; and (iii) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>No
Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement, the Warrant Agreement, the Representative&rsquo;s
Unit Purchase Option and all ancillary documents, the consummation by the Company of the transactions herein and therein contemplated
and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse
of time or both: (i) result in a material breach of, or conflict with any of the terms and provisions of, or constitute a material default
under, or result in the creation, modification, termination or imposition of any material lien, charge or encumbrance upon any property
or assets of the Company pursuant to the terms of any agreement or instrument to which the Company is a party; (ii) result in any violation
of the provisions of the Company&rsquo;s certificate of incorporation (as the same may be amended or restated from time to time, the &ldquo;<U>Charter</U>&rdquo;)
or the by-laws of the Company (as the same may be amended or restated from time to time, the &ldquo;<U>Bylaws</U>&rdquo;); or (iii) violate
any existing law, rule, regulation, judgment, order or decree of any Governmental Entity applicable to the Company as of the date hereof
(including, without limitation, those promulgated by the Food and Drug Administration of the U.S. Department of Health and Human Services
(the &ldquo;<U>FDA</U>&rdquo;) or by any foreign, federal, state or local regulatory authority performing functions similar to those performed
by the FDA), except in the case of clauses (i) and (iii) above for any such breaches, conflicts or violations which would not reasonably
be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory</U>.
Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus or as would not reasonably be expected
to result, individually or in the aggregate, in a Material Adverse Change: (i) the Company has not received any FDA Form 483, written
notice of adverse finding, warning letter or other correspondence or written notice from the FDA or any other Governmental Entity alleging
or asserting noncompliance with any Applicable Laws (as defined in clause (ii) below) or Authorizations (as defined in clause (iii) below);
(ii) the Company is and has been in material compliance with statutes, laws, ordinances, rules and regulations applicable to the Company,
including, without limitation, all statutes, laws, ordinances, rules and regulations for the ownership, testing, development, manufacture,
packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of
any product manufactured or distributed by the Company, including without limitation, the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
&sect; 301, et seq., similar laws of other Governmental Entities and the regulations promulgated pursuant to such laws (collectively,
&ldquo;<U>Applicable Laws</U>&rdquo;); (iii) the Company possesses all licenses, certificates, approvals, clearances, consents, authorizations,
qualifications, registrations, permits, and supplements or amendments thereto required by any such Applicable Laws and/or to carry on
its businesses as now conducted (&ldquo;<U>Authorizations</U>&rdquo;) and such Authorizations are valid and in full force and effect and
the Company is not in violation of any term of any such Authorizations; (iv) the Company has not received written notice of any claim,
action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party
alleging that any product, operation or activity is in violation of any Applicable Laws or Authorizations or has any knowledge that any
such Governmental Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding,
nor, to the Company&rsquo;s knowledge, has there been any material noncompliance with or violation of any Applicable Laws by the Company
that could reasonably be expected to require the issuance of any such communication or result in an investigation, corrective action,
or enforcement action by FDA or other Governmental Entity; (v) the Company has not received written notice that any Governmental Entity
has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations or has any knowledge that any such
Governmental Entity has threatened or is considering such action; (vi) the Company has filed, obtained, maintained or submitted all reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws
or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or
amendments were, in all material respects, complete, correct and not misleading on the date filed (or were corrected or supplemented by
a subsequent submission); and (vii) the Company has not, either voluntarily or involuntarily, initiated, conducted or issued, or caused
to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post-sale warning, &ldquo;dear doctor&rdquo;
letter, or other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged product defect or violation
and, to the Company&rsquo;s knowledge, no third party has initiated, conducted or intends to initiate or conduct such notice or action.
Neither the Company nor, to the Company's knowledge, any of its directors, officers, employees or agents (in their capacities as such)
has been convicted of any crime under any Applicable Laws or has been the subject of an FDA debarment proceeding. The Company has not
been or is now subject to FDA's Application Integrity Policy. To the Company's knowledge, neither the Company, nor any of its directors,
officers, employees or agents (in their capacities as such), has made, or caused the making of, any false statements on, or material omissions
from, any other records or documentation prepared or maintained to comply with the requirements of the FDA or any other Governmental Entity.
Neither the Company nor, to the Company's knowledge, any of its directors, officers, employees or agents (in their capacities as such),
have with respect to each of the following statutes, or regulations promulgated thereto, as applicable: (i) engaged in activities under
42 U.S.C. &sect;&sect; 1320a-7b or 1395nn; (ii) knowingly engaged in any activities under 42 U.S.C. &sect; 1320a-7b or the Federal False
Claims Act, 31 U.S.C. &sect; 3729; or (iii) knowingly and willfully engaged in any activities under 42 U.S.C.&sect; 1320a-7b, which are
prohibited, cause for civil penalties, or mandatory or permissive exclusion from Medicare, Medicaid, or any other State Health Care Program
or Federal Health Care Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Clinical
Studies</U>. The studies, tests and clinical trials conducted by or on behalf of the Company were and, if still pending, are being conducted
in accordance with experimental protocols, procedures and controls pursuant to all Applicable Laws and Authorizations, except where such
failure to comply would not, individually or in the aggregate, result in a Material Adverse Change; the descriptions of the results of
such studies, tests and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate
and complete in all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has no knowledge of any studies, tests or
trials, the results of which the Company believes reasonably call into question the study, test, or trial results described or referred
to in the Registration Statement, the pricing Disclosure Package and the Prospectus when viewed in the context in which such results are
described and the clinical state of development; and the Company has not received any written notices or correspondence from any Governmental
Entity requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted
by or on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>No
Defaults; Violations</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no default
exists in the due performance and observance of any term, covenant or condition of any material license, contract, indenture, mortgage,
deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any
other material agreement or instrument to which the Company is a party or by which the Company may be bound or to which any of the properties
or assets of the Company is subject, except as would not reasonably be expected to result, individually or in the aggregate, in a Material
Adverse Change. The Company is not (i) in violation of any term or provision of its Charter or Bylaws, or (ii) except as would not reasonably
be expected to result, individually or in the aggregate, in a Material Adverse Change, in violation of any franchise, license, permit,
applicable law, rule, regulation, judgment or decree of any Governmental Entity applicable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>Corporate
Power; Licenses; Consents</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Conduct
of Business</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has
all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits
of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business purpose as described
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where such failure to have such necessary authorizations,
approvals, orders, licenses, certificates and permits would not reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Transactions
Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions
and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained. No
consent, authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance,
sale and delivery of the Public Securities and the consummation of the transactions and agreements contemplated by this Agreement and
as contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, except with respect to applicable federal
and state securities laws, the rules and regulations of the Financial Industry Regulatory Authority, Inc. (&ldquo;<U>FINRA</U>&rdquo;)
and the rules and regulations of the Exchange, and except with respect to such consent, authorization, order or filing that would not
reasonably be expected to have a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Litigation;
Governmental Proceedings</U>. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental
proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company or, to the Company&rsquo;s knowledge,
any executive officer or director which has not been disclosed in the Registration Statement, the Pricing Disclosure Package, the Prospectus
or in connection with the Company&rsquo;s listing application for the additional listing of the Shares on the Exchange and which is required
to be disclosed, in each case individually or in the aggregate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Good
Standing</U>. The Company has been duly organized and is validly existing as a corporation and is in good standing under the laws of the
State of Delaware as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction in which
its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify, singularly
or in the aggregate, would not have or reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>Insurance</U>.
The Company carries or is entitled to the benefits of insurance, with, to the Company&rsquo;s knowledge, reputable insurers, and in such
amounts and covering such risks which the Company believes are reasonably adequate, and all such insurance is in full force and effect.
The Company has no reason to believe that it will not be able (i) to renew its existing insurance coverage as and when such policies expire
or (ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted
and at a cost that would not reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Transactions
Affecting Disclosure to FINRA</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Finder&rsquo;s
Fees</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no claims, payments,
arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting or origination fee by the Company or
any executive officer or director of the Company (each, an, &ldquo;<U>Insider</U>&rdquo;) with respect to the sale of the Public Securities
hereunder or any other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders
that may affect the Underwriters&rsquo; compensation, as determined by FINRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Payments
Within 180 Days</U>. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i)&nbsp;any U.S.
person, as a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing
to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii)&nbsp; any person or entity that
has any direct or indirect affiliation or association with any FINRA member, within the 180 days prior to the date of the initial filing
of the Registration Statement, other than the payment to the Underwriters as provided hereunder in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Use
of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates,
except as specifically authorized herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) <U>FINRA
Affiliation</U>. There is no (i) officer or director of the Company, (ii) to the Company&rsquo;s knowledge, beneficial owner of 5% or
more of any class of the Company's securities or (iii) to the Company&rsquo;s knowledge, beneficial owner of the Company's unregistered
equity securities which were acquired during the 180-day period immediately preceding the filing of the Registration Statement that, in
each such case, is an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with
the rules and regulations of FINRA).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v) <U>Information</U>.
To the Company&rsquo;s knowledge, all information provided by the Company&rsquo;s officers and directors in their FINRA Questionnaires
to Representative&rsquo;s Counsel specifically for use by Representative&rsquo;s Counsel in connection with its Public Offering System
filings (and related disclosure) with FINRA is true, correct and complete in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) &nbsp;<U>Foreign
Corrupt Practices Act</U>. Neither the Company nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate
of the Company (acting in such capacity) or any other person acting on behalf of the Company (acting in such capacity), has, directly
or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary
course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any governmental
agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign)
or other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection with any
actual or proposed transaction) that (i)&nbsp;might subject the Company to any damage or penalty in any civil, criminal or governmental
litigation or proceeding, (ii)&nbsp;if not given in the past, might reasonably been expected to have had a Material Adverse Change or
(iii)&nbsp;if not continued in the future, might adversely affect the assets, business, operations or prospects of the Company. The Company
has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all
material respects with the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) <U>Compliance
with OFAC</U>. Neither the Company nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate of the Company
(acting in such capacity) or any other person acting on behalf of the Company (acting in such capacity), is currently subject to any U.S.
sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) <U>Money
Laundering Laws</U>. The operations of the Company are and have been conducted at all times in compliance in all material respects with
applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;);
and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money Laundering Laws
is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) <U>Officers&rsquo;
Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative or to Representative&rsquo;s
Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) <U>Related
Party Transactions</U>. There are no business relationships or related party transactions involving the Company or any other person required
to be described in the Registration Statement, the Pricing Disclosure Package and the Prospectus that have not been described as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>Board of Directors</U>.
The qualifications of the persons serving as board members and the overall composition of the board comply with the Exchange Act, the
Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder (the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;)
applicable to the Company and the listing rules of the Exchange. At least one member of the Audit Committee of the Board of Directors
of the Company qualifies as an &ldquo;audit committee financial expert,&rdquo; as such term is defined under Regulation S-K and the listing
rules of the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Sarbanes-Oxley
Compliance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Disclosure
Controls</U>. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or
15d-15 under the Exchange Act Regulations applicable to it, and, except as described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, such controls and procedures are as of the date hereof effective to ensure that all material information concerning
the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&rsquo;s Exchange Act
filings and other public disclosure documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Compliance</U>.
The Company is in compliance with the provisions of the Sarbanes-Oxley Act applicable to it, and has implemented or will implement such
programs and taken reasonable steps to ensure the Company&rsquo;s future compliance (not later than the relevant statutory and regulatory
deadlines therefor) with all of the provisions of the Sarbanes-Oxley Act, except where the failure to be in compliance would not have
or reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Accounting Controls</U>.
The Company maintains systems of &ldquo;internal control over financial reporting&rdquo; (as defined under Rules 13a-15 and 15d-15 under
the Exchange Act Regulations) that comply in all material respects with the requirements of the Exchange Act and have been designed by,
or under the supervision of, its principal executive and principal financial officers, or persons performing similar functions, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that (i)
transactions are executed in accordance with management&rsquo;s general or specific authorizations; (ii) transactions are recorded as
necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to
assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has no knowledge of
any material weaknesses in its internal controls. The Auditors and the Audit Committee of the Board of Directors of the Company have been
advised of: (i) all significant deficiencies and material weaknesses, if any, in the design or operation of internal controls over financial
reporting which are known to the Company&rsquo;s management and that have adversely affected or are reasonably likely to adversely affect
the Company&rsquo; ability to record, process, summarize and report financial information; and (ii) any fraud, if any, known to the Company&rsquo;s
management, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal
controls over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No Investment Company
Status</U>. The Company is not and, after giving effect to the Offering and the application of the proceeds thereof as described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be, required to register as an &ldquo;investment company,&rdquo;
as defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>No Labor Disputes</U>.
No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is imminent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Intellectual Property
Rights</U>. To the Company&rsquo;s knowledge, the Company has, or can acquire on reasonable terms, ownership of and/or license to, or
otherwise has the right to use, all inventions, know-how (including trade secrets and other unpatented and/or unpatentable proprietary
or confidential information, systems or procedures), patents and patent rights trademarks, service marks and trade names and copyrights
(collectively &ldquo;<U>Intellectual Property</U>&rdquo;) material to carrying on its businesses as described in the Pricing Prospectus.
The Company has not received any written notice relating to any Intellectual Property, including written notice of: (A) infringement or
misappropriation of, or conflict with, any Intellectual Property of a third party; (B) asserted rights of others with respect to any Intellectual
Property of the Company; or (C) assertions that any Intellectual Property of the Company is invalid or otherwise inadequate to protect
the interest of the Company, that in each case (if the subject of any unfavorable decision, ruling or finding), individually or in the
aggregate, would have or would reasonably be expected to have a Material Adverse Change. To the Company&rsquo;s knowledge, there are no
third parties who have been able to establish any material rights to any Intellectual Property, except for the retained rights of the
owners or licensors of any Intellectual Property that is licensed to the Company. There is no pending or, to the Company&rsquo;s knowledge,
threatened action, suit, proceeding or claim by others: (A) challenging the validity, enforceability or scope of any Intellectual Property
of the Company in any material respect or (B) challenging the Company&rsquo;s rights in or to any Intellectual Property in any material
respect or (C) that the Company materially infringes, misappropriates or otherwise violates or conflicts with any Intellectual Property
or other proprietary rights of others. The Company has complied in all material respects with the terms of each agreement described in
the Registration Statement, Pricing Disclosure Package or Prospectus pursuant to which any Intellectual Property is licensed to the Company,
except for such noncompliance as did not have a Material Adverse Change, and all such agreements related to products currently made or
sold by the Company, or to product candidates currently under development, are in full force and effect. All patents issued in the name
of, or assigned to, or licensed to the Company, and all patent applications made by or on behalf of the Company (collectively, the &ldquo;<U>Company
Patents</U>&rdquo;) have been duly and properly filed, except for such failures to file as would reasonably be expected to result in a
Material Adverse Change. The Company has no knowledge of any material information that was required to be disclosed to the United States
Patent and Trademark Office (the &ldquo;<U>PTO</U>&rdquo;) but that was not disclosed to the PTO with respect to any issued Company Patent,
or that is required to be disclosed and has not yet been disclosed in any pending application in the Company Patents and that would preclude
the grant of a patent on such application. To the Company&rsquo;s knowledge, the Company is the sole owner or exclusive licensee of the
Company Patents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>Taxes</U>. The
Company has filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to the date hereof or has duly
obtained extensions of time for the filing thereof. The Company has paid all taxes (as hereinafter defined) shown as due on such returns
that were filed and has paid all taxes imposed on or assessed against the Company, except (i) such taxes the Company is challenging in
good faith and (ii) for such exceptions as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Change. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement
are sufficient for all material accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such
consolidated financial statements. Except as would not reasonably be expected to result in a Material Adverse Change, (i) no issues have
been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from the
Company, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes have been given by or requested
from the Company. The term &ldquo;<U>taxes</U>&rdquo; mean all federal, state, local, foreign and other net income, gross income, gross
receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment,
excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges
of any kind whatever, together with any interest and any penalties, additions to tax or additional amounts with respect thereto. The term
&ldquo;<U>returns</U>&rdquo; means all returns, declarations, reports, statements and other documents required to be filed in respect
to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Employee Benefit
Laws</U>. The operations of the Company are and have, in the last three (3) years, been conducted at all times in material compliance
with the Employee Retirement Income Security Act of 1974, as amended, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;<U>Employee Benefit
Laws</U>&rdquo;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company with respect to the Employee Benefit Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) <U>Compliance
with Laws</U>. The Company in the last three (3) years: (A) to its knowledge is and at all times has been in compliance with all Applicable
Laws, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (B) has not received
any written correspondence from any Governmental Entity alleging or asserting noncompliance with any Applicable Laws or any Authorizations;
(C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and the Company is not in material
violation of any term of any such Authorizations, in each case except as would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Change; (D) has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation,
arbitration or other action from any Governmental Entity or third party alleging that any product operation or activity is in violation
of any Applicable Laws or Authorizations and has no knowledge that any such Governmental Entity or third party is considering any such
claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received written notice that any Governmental Entity
has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations; and (F) has filed, obtained, maintained
or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments
as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments were complete and correct in all material respects on the date filed (or were corrected or supplemented
by a subsequent submission).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Ineligible Issuer</U>. At
the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness of the Registration
Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant made a bona fide
offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities and at the date hereof, the Company
was not and is not an &ldquo;ineligible issuer,&rdquo; as defined in Rule 405, without taking account of any determination by the Commission
pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Industry Data</U>.&nbsp;
The statistical and market-related data included in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus
are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the
Company&rsquo;s good faith estimates that are made on the basis of data derived from such sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Forward-Looking
Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable
basis or has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Website</U>. To
the knowledge of the Company, none of the information on (or hyperlinked from) the Company&rsquo;s website at www.aditxt.com includes
or constitutes a &ldquo;free writing prospectus&rdquo; as defined in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Emerging Growth
Company</U>. The Company is an &ldquo;emerging growth company,&rdquo; as defined in Section 2(a) of the Securities Act (an &ldquo;<U>Emerging
Growth Company</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo) <U>Margin
Securities</U>. The Company owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of Governors
of the Federal Reserve System (the &ldquo;<U>Federal Reserve Board</U>&rdquo;), and none of the proceeds of Offering will be used, directly
or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness
which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the Common Shares
to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or X of the Federal Reserve Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Integration</U>.
Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering to be integrated
with prior offerings by the Company for purposes of the Securities Act that would require the registration of any such securities issued
in such prior offerings under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>Confidentiality
and Non-Competition</U>. To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the Company is subject
to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer (other than the Company)
or prior employer that could reasonably be expected to materially affect his ability to be and act in his respective capacity of the Company
or reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>Smaller Reporting
Company</U>. The Company is a &ldquo;smaller reporting company,&rdquo; as defined in Rule 12b-2 of the Exchange Act Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">3. <U>Covenants
of the Company</U>. The Company covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Amendments
to Registration Statement</U>. The Company shall deliver to the Representative, prior to filing, any amendment or supplement to the Registration
Statement or Prospectus proposed to be filed after the Effective Date and not file any such amendment or supplement to which the Representative
shall reasonably object in writing; provided however, that this Section 3(a) shall not be applicable with respect to any supplements to
the Registration Statement filed solely for the purpose of supplementing the Registration Statement or Prospectus with a report filed
with the Commission by the Company pursuant to the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Federal
Securities Laws</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Compliance</U>.
The Company shall comply with the requirements of Rule 430A of the Securities Act Regulations, and will notify the Representative promptly,
and confirm the notice in writing, (i)&nbsp;when any amendment or supplement to the Prospectus shall have been filed; (ii)&nbsp;of the
receipt of any comments from the Commission related to the Prospectus or Offering; (iii)&nbsp;of any request by the Commission for any
amendment or supplement to the Prospectus or for additional information; (iv)&nbsp;of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing or suspending the
use of any Preliminary Prospectus or the Prospectus, or of the suspension of the qualification of the Public Securities and Representative&rsquo;s
Securities for offering or sale in any jurisdiction, or of the initiation or, to the Company&rsquo;s knowledge, threatening, of any proceedings
for any of such purposes or of any examination pursuant to Section&nbsp;8(d) or 8(e) of the Securities Act concerning the Registration
Statement; and (v)&nbsp;if the Company becomes the subject of a proceeding under Section&nbsp;8A of the Securities Act in connection with
the Offering of the Public Securities and Representative&rsquo;s Securities. The Company shall effect all filings required under Rule
424(b) of the Securities Act Regulations, in the manner and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)),
and shall take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted for filing under Rule
424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such prospectus. The Company
shall use its commercially reasonable efforts to prevent the issuance of any stop order, prevention or suspension and, if any such order
is issued, to obtain the lifting thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Continued
Compliance</U>. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the Exchange Act
Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement and in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. If at any time when a prospectus relating to the Public Securities is (or,
but for the exception afforded by Rule 172 of the Securities Act Regulations (&ldquo;<U>Rule 172</U>&rdquo;), would be) required by the
Securities Act to be delivered in connection with sales of the Public Securities, any event shall occur or condition shall exist as a
result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i) amend or supplement the Pricing
Disclosure Package or the Prospectus in order that the Pricing Disclosure Package or the Prospectus, as the case may be, will not include
any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading
in the light of the circumstances existing at the time it is delivered to a purchaser or (ii) amend the Registration Statement or amend
or supplement the Pricing Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the Securities
Act or the Securities Act Regulations, the Company will promptly (A) give the Representative notice of such event; (B) prepare any amendment
or supplement as may be necessary to correct such statement or omission or to make the Registration Statement, the Pricing Disclosure
Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish
the Representative with copies of any such amendment or supplement and (C) file with the Commission any such amendment or supplement;
provided that the Company shall not file or use any such amendment or supplement to which the Representative or counsel for the Representative
shall reasonably object. The Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters
may reasonably request. The Company has given the Representative notice of any filings made pursuant to the Exchange Act or the Exchange
Act Regulations within 48 hours prior to the Applicable Time. The Company shall give the Representative notice of its intention to make
any such filing from the Applicable Time until the later of the Closing Date and the exercise in full or expiration of the Over-allotment
Option specified in Section 1(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Exchange
Act Registration</U>. The Company shall use its commercially reasonable efforts to maintain the registration of the Common Shares under
the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Delivery
to the Underwriters of Prospectuses</U>. The Company has delivered or made available or will deliver or make available to each Underwriter,
without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company hereby consents
to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter, without charge,
during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule 172, would be) required
to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may
reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically
transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Events
Requiring Notice to the Representative</U>. During the period when a prospectus relating to the Public Securities is (or, but for the
exception afforded by Rule 172, would be) required by the Securities Act to be delivered in connection with sales of the Public Securities,
the Company shall notify the Representative immediately and confirm the notice in writing: (i)&nbsp;of the issuance by the Commission
of any stop order or of the initiation, or to the Company&rsquo;s knowledge, the threatening, of any proceeding for that purpose; (ii)&nbsp;of
the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Public Securities for
offering or sale in any jurisdiction or of the initiation, or to the Company&rsquo;s knowledge, the threatening, of any proceeding for
that purpose; (iii)&nbsp;of the delivery to the Commission for filing of any amendment or supplement to the Prospectus; (iv)&nbsp;of the
receipt of any comments or request for any additional information from the Commission related to the Prospectus; and (v)&nbsp;of the happening
of any event during the period described in this Section 3(e) that, in the judgment of the Company, makes any statement of a material
fact made in the Pricing Disclosure Package or the Prospectus untrue or that requires the making of any changes in in the Pricing Disclosure
Package or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
If the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company shall
use its commercially reasonable efforts to obtain promptly the lifting of such order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Listing</U>.
The Company shall use its commercially reasonable efforts to maintain the listing of the shares of Common Shares on the Exchange for a
period of three (3) years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Transfer
Agent; Warrant Agent</U>. The Company shall maintain a transfer agent and registrar for the Common Stock and a Warrant Agent for the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Payment
of Expenses</U>. The Company hereby agrees to pay on each of the Closing Dates, as applicable and without duplication, all expenses incident
to the performance of the obligations of the Company under this Agreement, including, but not limited to: (a) all filing fees and expenses
relating to the registration of the Public Securities with the Commission; (b) all FINRA Public Offering filing fees; (c) all fees and
expenses relating to the listing of the Public Securities on the Exchange; (d) all fees, expenses and disbursements, if any, relating
to the registration or qualification of the Public Securities under the &ldquo;blue sky&rdquo; securities laws of such states and other
jurisdictions as the Underwriter may reasonably designate (including, without limitation, all filing and registration fees, and the reasonable
fees and disbursements of &ldquo;blue sky&rdquo; counsel); (e) all fees, expenses and disbursements relating to the registration, qualification
or exemption of the Public Securities under the securities laws of such foreign jurisdictions as the Underwriter may reasonably designate;
(f) the costs of all mailing and printing of the Offering documents; (g) transfer and/or stamp taxes, if any, payable upon the transfer
of Public Securities from the Company to the Underwriters; (h) fees and expenses of Representative&rsquo;s Counsel; and (i) expenses related
to lucite tombstones and mementos and &ldquo;road show&rdquo; expenses; provided that the aggregate amount of fees and expenses reimbursable
pursuant to (h) and (i) above shall not exceed $135,000. The Representative may deduct from the net proceeds of the Offering payable to
the Company on the Closing Date, the expenses set forth herein (less any amounts previously advanced against such actual reimbursable
expense) to be paid by the Company to the Underwriters, provided, however, that in the event that the Offering is terminated, the Company
agrees to reimburse the Underwriters pursuant to Section 8(c) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Application
of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent with the application
thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Rule
158</U>. The Company will timely file such reports pursuant to the Exchange Act as are necessary in order to make generally available
to its security holders as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriters the benefits
contemplated by, Rule 158(a) under Section 11(a) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Stabilization</U>.
Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent of the Representative)
has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to
cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of the Public Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>FINRA</U>.
For a period of 90 days from the later of the Closing Date or Option Closing Date, the Company shall advise the Representative (who shall
make an appropriate filing with FINRA) if it has knowledge that (i) any officer or director of the Company, (ii) any beneficial owner
of 5% or more of any class of the Company's securities or (iii) any beneficial owner of the Company's unregistered equity securities which
were acquired during the 180 days immediately preceding the filing of the Registration Statement, is or becomes an affiliate or associated
person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations of FINRA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>No
Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely contractual
in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary capacity,
or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other transactions
contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Reporting
Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded
by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed with the Commission
pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>OFAC</U>.
The Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person
currently subject to any U.S. sanctions administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Company
Lock-Up Agreement</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior written consent of the
Representative, it will not, for a period of ninety (90) days after the date of this Agreement (the &ldquo;<U>Lock-Up Period</U>&rdquo;),
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company
or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company. The restrictions contained
in this Section 3(o) shall not apply to (i) the Common Shares and Warrants to be sold hereunder and the issuance of the Representative&rsquo;s
Unit Purchase Option, (ii) the issuance by the Company of Common Shares upon the exercise of a stock option or warrant or the conversion
of a security outstanding on the date hereof and disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus,
(iii) the issuance by the Company of stock options or shares of capital stock of the Company under any equity compensation plan of the
Company disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, and (iv) any securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, and provided that any
such issuance shall only be to a person (or to the equityholders of a person) which is, itself or through its subsidiaries, an operating
company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional
benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily
for the purpose of raising capital or to an entity whose primary business is investing in securities (each, an &ldquo;<U>Exempt Issuance</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4. <U>Conditions
of Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Public Securities, as provided
herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date hereof and
as of each of the Closing Date, and any Option Closing Date; (ii) the accuracy of the statements of officers of the Company made pursuant
to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Regulatory
Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Effectiveness
of Registration Statement</U>. The Registration Statement is effective, and, at each of the date hereof, the Closing Date, and the Option
Closing Date, if applicable, no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment
thereto has been issued under the Securities Act, no order preventing or suspending the use of any Preliminary Prospectus or the Prospectus
has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&rsquo;s knowledge,
contemplated by the Commission. The Company has complied with each request (if any) from the Commission for additional information. The
Prospectus shall have been filed with the Commission in the manner and within the time frame required by Rule 424(b) (without reliance
on Rule 424(b)(8)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>FINRA
Clearance</U>. On or before the Closing Date, the Representative shall have received clearance from FINRA as to the amount of compensation
allowable or payable to the Underwriters as described in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Exchange
Stock Market Clearance</U>. On the Closing Date, the Company shall have received notice from the Exchange that it has no objections to
the issuance and sale of the Public Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Company
Counsel Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Closing
Date Opinion of Counsel.</U> On the Closing Date, the Representative shall have received the favorable opinion and negative assurance
letter of Sheppard, Mullin, Richter&nbsp;&amp; Hampton&nbsp;LLP, counsel to the Company, dated the Closing Date and addressed to the Representative,
substantially in form and substance reasonably satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Option
Closing Date Opinion of Counsel.</U> On each Option Closing Date, if any, the Representative shall have received the favorable opinion
of Sheppard, Mullin, Richter&nbsp;&amp; Hampton&nbsp;LLP, dated the Option Closing Date, addressed to the Representative and in form and
substance reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made by such counsel
in its respective opinions delivered on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) <U>Reliance</U>.
In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other than the laws of the United
States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified in such opinion,
if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representative) of other counsel reasonably
acceptable to the Representative, familiar with the applicable laws; and (ii) as to matters of fact, to the extent they deem proper, on
certificates or other written statements of officers of the Company and officers of departments of various jurisdictions having custody
of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements or certificates
shall be delivered to Representative&rsquo;s Counsel if requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Comfort
Letters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Comfort
Letter</U>. At the time this Agreement is executed, the Representative shall have received from the Auditor a cold comfort letter containing
statements and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements
and certain financial information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus, addressed
to the Representative and in form and substance satisfactory in all respects to the Representative and to the Auditor, dated as of the
date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Bring-Down
Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received from the Auditor
a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms the statements
made in the letter furnished pursuant to Section 4(c)(i), except that the specified date referred to shall be a date not more than three
(3) business days prior to the Closing Date or the Option Closing Date, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) &nbsp;<U>Officers&rsquo;
Certificates</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Officers&rsquo;
Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date and any Option Closing Date,
as applicable, of its President and Chief Executive Officer and its Chief Financial Officer stating (on behalf of the Company and not
in an individual capacity) that (i) such officers have carefully examined the Registration Statement, the Pricing Disclosure Package,
and the Prospectus and, to their knowledge, the Registration Statement and each amendment thereto, as of the Applicable Time and as of
the Closing Date or Option Closing Date, as applicable, did not include any untrue statement of a material fact and did not omit to state
a material fact required to be stated therein or necessary to make the statements therein not misleading, and the Pricing Disclosure Package,
as of the Applicable Time and as of the Closing Date or Option Closing Date, as applicable, the Prospectus and each amendment or supplement
thereto, as of the respective date thereof and as of the Closing Date or Option Closing Date, as applicable, did not include any untrue
statement of a material fact and did not omit to state a material fact necessary in order to make the statements therein, in the light
of the circumstances in which they were made, not misleading, (ii) since the effective date of the Registration Statement, no event has
occurred which should have been set forth in a supplement or amendment to the Registration Statement, the Pricing Disclosure Package or
the Prospectus, (iii) to their knowledge after reasonable investigation, as of the Closing Date or Option Closing Date, as applicable,
the representations and warranties of the Company in this Agreement are true and correct in all material respects (except for those representations
and warranties qualified as to materiality, which shall be true and correct in all respects and except for those representations and warranties
which refer to facts existing at a specific date, which shall be true and correct as of such date) and the Company has complied with all
agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or Option Closing
Date, as applicable, and (iv) there has not been, subsequent to the date of the most recent audited financial statements included in the
Pricing Disclosure Package, any Material Adverse Change, or any change or development that, singularly or in the aggregate, would reasonably
be expected to involve a Material Adverse Change, except as set forth in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Secretary&rsquo;s
Certificate</U>. At each of the Closing Date or Option Closing Date, as applicable, the Representative shall have received a certificate
of the Company signed by the Secretary of the Company, dated the Closing Date, or Option Closing Date, as applicable, certifying: (i)&nbsp;that
each of the Charter and Bylaws is true and complete, has not been modified and is in full force and effect; (ii)&nbsp;that the resolutions
of the Company&rsquo;s Board of Directors relating to the Offering are in full force and effect and have not been modified; (iii) the
good standing of the Company; and (iv)&nbsp;as to the incumbency of the officers of the Company. The documents referred to in such certificate
shall be attached to such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>No
Material Changes</U>. Prior to and on each of the Closing Date or Option Closing Date, as applicable: (i)&nbsp;there shall have been no
Material Adverse Change that, singularly or in the aggregate, would reasonably be expected to involve a Material Adverse Change, from
the latest dates as of which such condition is set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus;
(ii)&nbsp;no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Insider
before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling or
finding would reasonably be expected to result in a Material Adverse Change, except as set forth in the Registration Statement, the Pricing
Disclosure Package and the Prospectus; (iii)&nbsp;no stop order shall have been issued under the Securities Act and no proceedings therefor
shall have been initiated or threatened by the Commission; and (iv)&nbsp;the Registration Statement, the Pricing Disclosure Package and
the Prospectus and any amendments or supplements thereto shall contain all material statements which are required to be stated therein
in accordance with the Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements
of the Securities Act and the Securities Act Regulations, and neither the Registration Statement, the Pricing Disclosure Package nor the
Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Other
Agreements to be Delivered</U>. On the Closing Date, the Company shall have delivered to the Representative an executed copy of the Warrant
Agreement and the Representative&rsquo;s Unit Purchase Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Additional
Documents</U>. At the Closing Date or Option Closing Date, as applicable, Representative&rsquo;s Counsel shall have been furnished with
such documents and opinions as they may reasonably require for the purpose of enabling Representative&rsquo;s Counsel to deliver an opinion
to the Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the
conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities
and Representative&rsquo;s Securities as herein contemplated shall be satisfactory in form and substance to the Representative and Representative&rsquo;s
Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5. <U>Indemnification.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Indemnification
of the Underwriters</U>. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates and each person controlling
such Underwriter (within the meaning of Section 15 of the Securities Act), and the directors, officers, agents and employees of each Underwriter,
its affiliates and each such controlling person (each Underwriter, and each such entity or person hereafter is referred to as an &ldquo;<U>Indemnified
Person</U>&rdquo;) from and against any losses (other than losses of profits), claims, damages, judgments, assessments, costs and other
liabilities (collectively, the &ldquo;<U>Liabilities</U>&rdquo;), and shall reimburse each Indemnified Person for all fees and expenses
(including the reasonable fees and expenses of counsel for the Indemnified Persons, except as otherwise expressly provided in this Agreement)
(collectively, the &ldquo;<U>Expenses</U>&rdquo;) and agrees to advance payment of such Expenses as they are incurred by an Indemnified
Person in investigating, preparing, pursuing or defending any actions, whether or not any Indemnified Person is a party thereto, arising
out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (i) the Registration Statement,
the Pricing Disclosure Package, the Preliminary Prospectus, or the Prospectus (as from time to time each may be amended and supplemented);
(ii) any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the
Offering, including any &ldquo;road show&rdquo; or investor presentations made to investors by the Company (whether in person or electronically);
or (iii) any application or other document or written communication (in this Section 5, collectively called &ldquo;application&rdquo;)
executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the Public
Securities and Representative&rsquo;s Securities under the securities laws thereof or filed with the Commission, any state securities
commission or agency, the Exchange or any other national securities exchange; or the omission or alleged omission therefrom of a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading, unless such statement or omission was made in reliance upon, and in conformity with, the Underwriters&rsquo; Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Procedure</U>.
Upon receipt by an Indemnified Person of notice of an action against such Indemnified Person with respect to which indemnity may reasonably
be expected to be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure
by any Indemnified Person so to notify the Company shall not relieve the Company from any obligation or liability which the Company may
have on account of this Section 5 or otherwise to such Indemnified Person, except to the extent the Company is materially prejudiced as
a proximate result of such failure. An Indemnified Person shall have the right to require that the Company assume the defense of any such
action (including the employment of counsel designated by the Company and reasonably satisfactory to the Representative). Any Indemnified
Person shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and
employ counsel reasonably satisfactory to the Representative for the benefit of the Underwriters and the other Indemnified Persons or
(ii) such Indemnified Person shall have been advised that in the opinion of counsel that there is an actual or potential conflict of interest
that prevents (or makes it imprudent for) the counsel engaged by the Company for the purpose of representing the Indemnified Person, to
represent both such Indemnified Person and any other person represented or proposed to be represented by such counsel. The Company shall
not be liable for the fees and expenses of more than one separate counsel (together with local counsel), representing all Indemnified
Persons who are parties to such action), which counsel (together with any local counsel) for the Indemnified Persons shall be selected
by the Representative, subject to the Company&rsquo;s approval (which shall not be unreasonably withheld). The Company shall not be liable
for any settlement of any action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company
shall not, without the prior written consent of the Underwriters, settle, compromise or consent to the entry of any judgment in or otherwise
seek to terminate any pending or threatened action in respect of which advancement, reimbursement, indemnification or contribution may
be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination
(i) includes an unconditional release of that Indemnified Person from all Liabilities arising out of such action for which indemnification
or contribution may be sought hereunder and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure
to act, by or on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and contribution obligations of the
Company required hereby shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as
every Liability and Expense is incurred and is due and payable, and in such amounts as fully satisfy each and every Liability and Expense
as it is incurred (and in no event later than 30 days following the date of any invoice therefore); provided, however, that the Indemnified
Persons shall repay such amounts to the extent it ultimately is determined that such persons are not entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Indemnification
of the Company</U>. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors, its
officers, employees and persons who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act against any and all Liabilities, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions
made in the Registration Statement, any Preliminary Prospectus, the Pricing Disclosure Package or Prospectus or any amendment or supplement
thereto or in any application, in reliance upon, and in strict conformity with, the Underwriters&rsquo; Information. In case any action
shall be brought against the Company or any other person so indemnified based on any Preliminary Prospectus, the Registration Statement,
the Pricing Disclosure Package or Prospectus or any amendment or supplement thereto or in any application, and in respect of which indemnity
may be sought against any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each
other person so indemnified shall have the rights and duties given to the several Underwriters by the provisions of Section 5(b). The
Company agrees promptly to notify the Representative of the commencement of any litigation or proceedings against the Company or any of
its officers, directors or any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act, in connection with the issuance and sale of the Public Securities or in connection with the Registration Statement,
the Pricing Disclosure Package, or the Prospectus; provided that failure by the Company so to notify the Representative shall not relieve
any Underwriter from any obligation or liability which such Underwriter may have on account of this Section 5 or otherwise to the Company,
except to the extent such Underwriter is materially prejudiced as a proximate result of such failure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Contribution</U>.
If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient to hold harmless an indemnified
party under Section 5(a) or 5(c) in respect of any Liabilities and Expenses referred to therein, then each indemnifying party shall, in
lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such Liabilities
and Expenses, (i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand,
and each of the Underwriters, on the other hand, from the Offering, or (ii) if the allocation provided by clause (i) above is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but
also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, in connection with the matters as to
which such Liabilities or Expenses relate, as well as any other relevant equitable considerations. The relative benefits received by the
Company, on the one hand, and the Underwriters, on the other hand, with respect to such Offering shall be deemed to be in the same proportion
as the total proceeds from the Offering purchased under this Agreement (after deducting all underwriting discounts, commissions and other
fees but before deducting expenses) received by the Company bear to the total underwriting discount, fees and commissions actually received
by the Underwriters in connection with the Offering, in each case as set forth in the table on the cover page of the Prospectus. The relative
fault of the Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by the Company, on the one hand, or the Underwriters, on the other hand, and the parties&rsquo; relative intent,
knowledge, access to information and opportunity to correct or prevent such untrue statement, omission, act or failure to act; provided
that the parties hereto agree that the written information furnished to the Company through the Representative by or on behalf of any
Underwriter for use in any Preliminary Prospectus, any Registration Statement or the Prospectus, or in any amendment or supplement thereto,
consists solely of the Underwriters&rsquo; Information. The Company and the Underwriters agree that it would not be just and equitable
if contributions pursuant to this subsection (d) were determined by pro rata allocation (even if the Underwriters were treated as one
entity for such purpose) or by any other method of allocation which does not take into account the equitable considerations referred to
above in this subsection (d). Notwithstanding the above, no person guilty of fraudulent misrepresentation within the meaning of Section
11(f) of the Securities Act shall be entitled to contribution from a party who was not guilty of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Survival</U>.
The advancement, reimbursement, indemnity and contribution obligations set forth in this Section 5 shall remain in full force and effect
regardless of any termination of, or the completion of any Indemnified Person's services under or in connection with, this Agreement.
Each Indemnified Person is an intended third-party beneficiary of this Section 5, and has the right to enforce the provisions of Section
5 as if he/she/it was a party to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">6. <U>Default
by an Underwriter.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Default
Not Exceeding 10% of Public Securities</U>. If any Underwriter or Underwriters shall default in its or their obligations to purchase the
Firm Securities, and if the number of the Firm Securities with respect to which such default relates does not exceed in the aggregate
10% of the number of Firm Securities that all Underwriters have agreed to purchase hereunder, then such Firm Securities to which the default
relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Default
Exceeding 10% of Public Securities</U>. In the event that the default addressed in Section 6(a) relates to more than 10% of the Firm Securities,
the Representative may in its discretion arrange for itself or for another party or parties to purchase such Firm Securities to which
such default relates on the terms contained herein. If, within thirty six (36) hours after such default relating to more than 10% of the
Firm Securities, the Representative does not arrange for the purchase of such Firm Securities, then the Company shall be entitled to a
further period of thirty six (36) hours within which to procure another party or parties satisfactory to the Representative to purchase
said Firm Securities on such terms. In the event that neither the Representative nor the Company arrange for the purchase of the Firm
Securities to which a default relates as provided in this Section 6, this Agreement will automatically be terminated by the Representative
or the Company without liability on the part of the Company (except as provided in Sections 3(f) and 5 hereof) or the several Underwriters
(except as provided in Section 5 hereof); provided that if any such default occurs with respect to any Option Shares, this Agreement will
not terminate in respect of the Firm Securities; and provided, further, that nothing herein shall relieve a defaulting Underwriter of
its liability, if any, to the other Underwriters and to the Company for damages occasioned by its default hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Postponement
of Closing Date</U>. In the event that the Firm Securities to which the default relates are to be purchased by the non-defaulting Underwriters,
or are to be purchased by another party or parties as aforesaid, the Representative or the Company shall have the right to postpone the
Closing Date for a reasonable period, but not in any event exceeding seven (7) Business Days, in order to effect whatever changes may
thereby be made necessary in the Registration Statement, the Pricing Disclosure Package or the Prospectus or in any other documents and
arrangements, and the Company agrees to file promptly any amendment to the Registration Statement, the Pricing Disclosure Package or the
Prospectus that in the opinion of counsel for the Underwriter may thereby be made necessary. The term &ldquo;<U>Underwriter</U>&rdquo;
as used in this Agreement shall include any party substituted under this Section 6 with like effect as if it had originally been a party
to this Agreement with respect to such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">7. <U>Additional
Covenants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Prohibition
on Variable Rate Transactions</U>. From the date hereof until one hundred eighty (180) days following the Closing Date, the Company shall
be prohibited from effecting or entering into an agreement to effect any issuance by the Company of Common Stock or Common Stock equivalents
(or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transactio</U>n&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial
issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some
future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly
or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined
price; provided, however, that this Section 7(a) shall not apply in respect of any at-the-market offering of Common Stock of Common Stock
or in respect of any Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Tail
Financing</U>. The Representative shall be entitled to fees set forth in this Agreement with respect to any public or private offering
or other financing or capital-raising transaction of any kind (&ldquo;<U>Tail Financing</U>&rdquo;) to the extent that such financing
or capital is provided to the Company by investors that participated in this offering, if such Tail Financing is consummated within the
twelve (12) month period following the Closing Date (the &ldquo;<U>Tail Period</U>&rdquo;). The Representative shall provide the Company
with a list of such investors who are subject to this Section 7(b) on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">8. <U>Effective
Date of this Agreement and Termination Thereof.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Effective
Date</U>. This Agreement shall become effective when both the Company and the Representative have executed the same and delivered counterparts
of such signatures to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Termination</U>.
The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i)&nbsp;if any domestic or
international event or act or occurrence has materially disrupted, or in Representative&rsquo;s opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii)&nbsp;if trading on the New York Stock Exchange or The Nasdaq Stock Market
LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges
for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction;
or (iii)&nbsp;if the United States shall have become involved in a new war or a material increase in major hostilities; or (iv)&nbsp;if
a banking moratorium has been declared by a New York State or federal authority; or (v)&nbsp;if a moratorium on foreign exchange trading
has been declared which materially adversely impacts the United States securities markets; or (vi)&nbsp;if the Company shall have sustained
a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or
not such loss shall have been insured, will, in Representative&rsquo;s opinion, make it inadvisable to proceed with the delivery of the
Firm Securities; or (vii)&nbsp;if the Company is in material breach of its representations, warranties or covenants hereunder; or (viii)&nbsp;if
the Representative shall have knowledge after the date hereof of such a Material Adverse Change in the conditions of the Company, or such
adverse material change in general market conditions, in each case, as in the Representative&rsquo;s judgment would make it impracticable
to proceed with the offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale
of the Public Securities. Section 5 of this Agreement shall survive any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Expenses</U>.
Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters pursuant to Section 6(b)
above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified herein or any extensions
thereof pursuant to the terms herein, the Company shall be obligated to pay to the Representative its actual and accountable out-of-pocket
expenses related to the transactions contemplated herein then due and payable up to a maximum of $135,000 in the aggregate and upon demand
the Company shall pay the full amount thereof (up to a maximum aggregate of $135,000) to the Representative (less amounts previously advanced
to the Underwriters); and provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions
of this Agreement. Notwithstanding the foregoing, any advance received by the Representative will be reimbursed to the Company to the
extent not actually incurred in compliance with FINRA Rule 5110(f)(2)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Indemnification</U>.
Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether
or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force and effect and shall not be in
any way affected by, such election or termination or failure to carry out the terms of this Agreement or any part hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Representations,
Warranties, Agreements to Survive</U>. All representations, warranties and agreements contained in this Agreement or in certificates of
officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i)&nbsp;any investigation
made by or on behalf of any Underwriter or its affiliates or selling agents, any person controlling any Underwriter, its officers or directors
or any person controlling the Company or (ii)&nbsp;delivery of and payment for the Public Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">9. <U>Miscellaneous.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) Notices.
All communications hereunder, except as herein otherwise specifically provided, shall be in writing and addressed to the other party at
its address set forth below (or to such other address that the receiving party may designate from time to time in accordance with this
Section 9(a)), and shall be deemed to have been given (a) three (3) days after mailing if sent by certified mail return receipt requested,
(b) one (1) day after mailing if sent by receipted overnight carrier (i.e. Federal Express), provided that proof of delivery or rejection
is obtained, or (c) when delivered if by hand or sent by email to the physical address or email address set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to the Representative:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Dawson James Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">1 North Federal Highway &ndash; 5th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Boca Raton, FL 33432</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: bob@dawsonjames.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Robert D. Keyser, Jr.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">With copies to (<I>which shall not constitute notice</I>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Schiff Hardin LLP<BR>
901 K Street, NW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Suite 700<BR>
Washington, DC 20001<BR>
redemartino@schiffhardin.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Ralph V. De Martino</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Aditxt, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">737 N. Fifth Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Suite 200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Richmond, VA 23219</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attention: Amro Albanna</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With copies to (<I>which shall
not constitute notice</I>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">Sheppard, Mullin, Richter&nbsp;&amp;
Hampton&nbsp;LLP<BR>
30 Rockefeller Plaza</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">New York, NY 10112-0015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">rafriedman@sheppardmullin.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">Attention: Richard A.
Friedman<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Headings</U>.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Amendment</U>.
This Agreement may only be amended by a written instrument executed by each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Entire
Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this
Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Binding
Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters, each Indemnified
Person referred to in Section 5, the Company and the controlling persons, directors and officers referred to in Section 5 hereof, and
their respective successors, legal representatives, heirs and assigns, and no other person shall have or be construed to have any legal
or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term
&ldquo;successors and assigns&rdquo; shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Governing
Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in accordance with the
laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action,
proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in the state and
federal courts sitting in the County, City and State of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall
be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.
Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail,
return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9(a) hereof. Such mailing shall be deemed
personal service and shall be legal and binding upon the Company in any action, proceeding or claim. THE COMPANY (ON ITS BEHALF AND, TO
THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS STOCKHOLDERS AND AFFILIATES) AND EACH OF THE UNDERWRITERS HEREBY IRREVOCABLY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR
RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Execution
in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts,
each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall
become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other parties
hereto. Delivery of a signed counterpart of this Agreement by email/pdf transmission shall constitute valid and sufficient delivery thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Waiver,
etc</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or
construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision hereof or the
right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by
the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>[<I>Signature Page Follows</I>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps">[Signature
Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Underwriting
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If the foregoing correctly sets forth the understanding
between the Underwriters and the Company, please so indicate in the space below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-variant: small-caps"><B>Aditxt, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Amro Albanna</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">Amro Albanna</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD> Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt">Confirmed as of the date first written above mentioned, on behalf of itself and as Representative of the several Underwriters named on <U>Schedule 1</U> hereto:</TD>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4"><FONT STYLE="font-variant: small-caps"><B>Dawson James Securities, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Robert D. Keyser, Jr.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 31%">Robert D. Keyser, Jr.</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Underwriter</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total&nbsp;Number<BR>
&nbsp;of Firm<BR>
 Securities to<BR>
 be Purchased</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Dawson James Securities, Inc.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">16,757,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,757,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>SCHEDULE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pricing Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Firm Shares or Pre-Funded Warrants: 16, 575,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Firm Warrants: 26,575,000 Series C warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Option Shares: 2,486,250</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Option Warrants: 2,486,250 Series C warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Offering Price per one Firm Share and one Warrant: $1.05</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriting Discount per one Firm Share and one Warrant: $0.0735 (7.0%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriting Discount per one Firm Share and one Warrant: $0.9765</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Offering Price per Option Share: $1.04</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriting Discount per Option Share: $0.0728</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purchase Price per Option Share: $0.9673</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Offering Price per Option Warrant: $0.01</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriting Discount per Option Warrant: $0.0007</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purchase Price Per Option Warrant: $0.0092</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form of Representative&rsquo;s Unit Purchase
Option</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-28-</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea151838ex5-1_aditxtinc.htm
<DESCRIPTION>SHEPPARD, MULLIN, RICHTER & HAMPTON LLP LEGAL OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
    <TD STYLE="width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sheppard, Mullin, Richter &amp; Hampton LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">30 Rockefeller Plaza</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10112-0015</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212.653.8700 main</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212.653.8701 fax</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.sheppardmullin.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">December 6, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>VIA ELECTRONIC MAIL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aditxt, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">737 N. Fifth Street, Suite 200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Richmond, VA 23219</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">Re:</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Registration Statement on Form S-3</U></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You have requested our opinion with respect to
certain matters in connection with the offering (the &ldquo;Offering&rdquo;) for sale by Aditxt, Inc. (the &ldquo;Company&rdquo;) of (i)
16,575,000 units (the &ldquo;Units&rdquo;), with each unit comprised of one share of the Company&rsquo;s common stock (the &ldquo;Shares&rdquo;)
and one Series C warrant (the &ldquo;Series C Warrants&rdquo;) to purchase one Share (the &ldquo;Series C Warrant Shares&rdquo;) and (ii)
Series C Warrants to be issued to the representative of the underwriters named in the Registration Statement (defined below) to purchase
up to 2,486,250 additional Shares (the &ldquo;Representative Shares&rdquo;) and/or Series C Warrants to puchase up to an additional 2,486,250
Shares (the &ldquo;Representative Warrants&rdquo;) in any combinations thereof, pursuant to the Registration Statement and the Prospectus
(as defined below). The Company also offered to those purchasers, if any, whose purchase of Units in the Offering would otherwise result
in such purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% of the Company&rsquo;s
Shares immediately following the consummation of the Offering, the opportunity, in lieu of purchasing Units, to purchase pre-funded units,
(the &ldquo;Pre-Funded Units&rdquo;), with each Pre-Funded Unit consisting of one pre-funded warrant to purchase one Share (the &ldquo;Pre-Funded
Warrants&rdquo; and together with the Series C Warrants, and the Representative Warrants, the &ldquo;Warrants&rdquo;) and one Series C
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless defined herein, capitalized terms have
the meanings given to them in that certain Underwriting Agreement (the &ldquo;Underwriting Agreement&rdquo;), dated December 1, 2021,
by and between the Company and Dawson James Securities, Inc., acting as the representative of the underwriters identified therein (the
&ldquo;Underwriters&rdquo;) relating to the Offering of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is being furnished in accordance
with the requirements of Item 601(b)(5)(i) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with this opinion, we have reviewed
and relied upon the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Registration Statement on Form S-3 (File No. 333-257645)
filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) which was declared effective on July 13, 2021, under
the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) (including any documents incorporated by reference therein,
the &ldquo;Registration Statement,&rdquo; and the related prospectus included in such Registration Statement (including any documents
incorporated by reference therein, the &ldquo;Base Prospectus&rdquo;));</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the final prospectus supplement, which includes the Base
Prospectus, filed December 1, 2021 pursuant to Rule 424(b) under the Securities Act, which is referred to as the &ldquo;Prospectus&rdquo;;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Underwriting Agreement;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Form of Series C Warrant;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Form of Series C Pre-Funded Warrant;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Amended and Restated Certificate of Incorporation of
the Company in effect on the date hereof;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the Amended and Restated Bylaws of the Company in effect
on the date hereof;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the resolutions of the Board of Directors of the Company,
adopted on November 30, 2021 authorizing/ratifying the execution and delivery of the Underwriting Agreement, the issuance and sale of
the Shares, the preparation and filing of the Prospectus, and other actions with regard thereto; and</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">such other documents, records, certificates, memoranda and
other instruments as we deem necessary as a basis for this opinion.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our examination, we have assumed the genuineness
of all signatures, including endorsements, the legal capacity and competency of all natural persons, the authenticity of all documents
submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified
or photocopy, and the authenticity of the originals of such copies. As to any facts relevant to the opinions stated herein that we did
not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the
Company and others and of public officials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing and subject to the qualifications
and assumptions stated herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Following (i)&nbsp;execution and delivery by the Company
of the Underwriting Agreement, (ii)&nbsp;effectiveness of the Registration Statement, (iii)&nbsp;issuance of the Shares pursuant to the
terms of the Underwriting Agreement, and (iv)&nbsp;receipt by the Company of the consideration for the Shares specified in the resolutions,
the Shares will be duly authorized for issuance and, when issued, delivered and paid for in accordance with the terms of the Agreement,
will be validly issued, fully paid and non-assessable.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">The Warrants have been duly authorized by all requisite corporate
action on the part of the Company under the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;) and, provided that
the &nbsp;Warrants have been duly executed and delivered by the Company and duly delivered to the purchasers thereof against payment
therefor, the Representatives&rsquo; Warrants, when issued and sold as contemplated in the Registration Statement will be valid and legally
binding obligations of the Company, enforceable against the Company in accordance with their terms, except as enforcement thereof may
be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors' rights generally
and by general equitable principles (regardless of whether such enforceability is considered in a proceeding at law or in equity).</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">The shares of Common Stock issuable upon exercise of the
Warrants (the &ldquo;Warrant Shares&rdquo; and together with the Shares, the &ldquo;Securities&rdquo;) have been duly authorized by all
requisite corporate action on the part of the Company under the DGCL and the laws of the State of New York and, when the Warrant Shares
are delivered to and paid for in accordance with the terms of the&nbsp; Representatives&rsquo; Warrants and when evidence of the issuance
thereof is duly recorded in the Company's books and records, the Warrant Shares will be validly issued, fully paid and non-assessable.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
letter as an exhibit to the Company&rsquo;s Current Report on Form 8-K being filed on the date hereof and incorporated by reference into
the Registration Statement. We also hereby consent to the reference to our firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus.
In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities
Act, the rules and regulations of the Commission promulgated thereunder or Item 509 of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We express no opinion as to matters governed by
any laws other than the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We disclaim any obligation to advise you of facts,
circumstances, events or developments that hereafter may be brought to our attention and that may alter, affect or modify the opinion
expressed herein. Our opinion is expressly limited to the matters set forth above and we render no opinion, whether by implication or
otherwise, as to any other matters relating to the Company or the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt">Respectfully submitted,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">/s/ Sheppard, Mullin, Richter &amp; Hampton LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">SHEPPARD, MULLIN, RICHTER &amp; HAMPTON LLP</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea151838ex99-1_aditxtinc.htm
<DESCRIPTION>PRESS RELEASE DATED DECEMBER 6, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 19.1pt 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 19.1pt 0pt 0; text-indent: 0in">Aditxt Announces Closing of $17.4
Million Firm Commitment Public Offering of Common Stock and Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aditxt, Inc. (&ldquo;Aditxt&rdquo;, or the &ldquo;Company&rdquo;) (Nasdaq:
ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the closing of its previously
announced underwritten public offering of 16,575,000 units, consisting of shares of its common stock and warrants to purchase up to 16,575,000
shares of its common stock at a public offering price of $1.05 per unit, for aggregate gross proceeds of $17,403,750, prior to deducting
underwriter discounts, commissions, and other offering expenses. Units were not issued or certificated. The shares of common stock and
warrants were issued separately. The warrants permit the holder to purchase one share of common stock at an exercise price of $1.15 per
share and expire five years after the date of issuance. T<FONT STYLE="font-family: Times New Roman, Times, Serif">he underwriter has a
45-day option to purchase up to 2,486,250 additional shares of common stock and/or warrants to purchase up to an aggregate of 2,486,250
shares of common stock, on one or more occasions and in any combinations thereof, from us at the public offering price, less the underwriting
discounts and commissions. The underwriter exercised the over-allotment option with respect to the warrants to purchase up to an aggregate
of 2,486,250 shares of common stock, which exercise also has closed. The underwriter continues to hold a 45-day option to purchase up
to 2,486,250 additional shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 5.9pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dawson James Securities, Inc. is acting as sole book-running
manager for the offering. Sheppard Mullin acted as counsel to Aditxt, and Schiff Hardin acted as counsel to the underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering of the common stock described above was made
pursuant to an effective &ldquo;shelf&rdquo; registration statement on Form S-3 (File No. 333-257645), that was previously filed with
the Securities and Exchange Commission (&quot;SEC&quot;) and declared effective by the SEC on July 13, 2021, and the base prospectus contained
therein. Such shares of common stock were offered by means of a prospectus, including a prospectus supplement. A prospectus supplement
and accompanying prospectus related to the offering of common stock was filed with the SEC and will be available on the SEC's website
located at http://www.sec.gov . Copies of the prospectus supplement and the accompanying prospectus relating to the offering of common
stock may be obtained, when available, by contacting Dawson James Securities, Inc., Attention: Prospectus Department, 101 North Federal
Highway, Suite 600, Boca Raton, FL, 33432, cwachowiz@dawsonjames.com or toll free at 866.928.0928.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release shall not constitute an offer to sell
or the solicitation of an offer to buy any securities nor were there any sales of these securities in any state or other jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or other jurisdiction.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">About Aditxt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aditxt is developing technologies specifically
focused on improving the health of the immune system through immune monitoring and reprogramming. Aditxt's immune monitoring technology
is designed to provide a personalized comprehensive profile of the immune system. Aditxt's immune reprogramming technology is currently
at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection
of transplanted organs, autoimmune diseases, and allergies. For more information, please visit: <U>www.aditxt.com</U> .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-Looking Statements</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Certain statements in this press
release constitute &quot;forward-looking statements&quot; within the meaning of federal securities laws. Forward-looking statements in
this press release include, without limitation, the ability of the Company to close the offering. Forward-looking statements include statements
regarding the Company's intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the
Company's ongoing and planned product and business development; the Company's intellectual property position; the Company's ability to
develop commercial functions; expectations regarding product launch and revenue; the Company's results of operations, cash needs, spending,
financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may
affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ
materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more
fully discussed in the section titled &quot;Risk Factors&quot; in the Company's most recent Annual Report on Form 10-K, as well as discussions
of potential risks, uncertainties, and other important factors in the Company's other filings with the Securities and Exchange Commission.
All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Media and Investor Relations Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aditxt, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@aditxt.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ; /H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#M?B)X^N_#
M-Q%I>F1I]JDC\UYI%W"-22!@=SP>OZUS"ZU\4FTI=6625[)D$H98;<DKZ[0-
MV._2NC^(>@>'M=OEEF\16&F:G GELL\R ,OW@&4D$'G.?0URDGA'QOX8L7N]
M-U/?91H9B;.Z.W;C.[8V ?7C->A15/V:2M?S/,K.I[1MMV\CJ_"_C;7[[3-2
M35=.DBN+:TDG@N3;LB.5'1@>,_3KSZ52\"?$35M<U^2WU:2SCLTM7F9U39MP
M5Y))Z<FL[PSX]U36;'5=)U9XYR]A,\4X0*P(0Y! &",=^.GO7(^!_#T?B;Q%
M'IT\LD<'E-+*8SAF"XX'XD52H1M/G5K$^WG>'([GOMKXN\/WMR+:VUFREF)P
MJ+,,L?;U_"M>:>*")I)71(U&69C@ >YKYV^(/A6T\+:U!;6;S/#/#YH$I!*G
M)&,U-XUUO4+W2/#MA//(T']FQ7#@G_6N2RY;U("_J:S^J*7*X/1FOUR4>936
MJ/:3XU\,K)L.O:?GU%PI'YYQ6M;WEM>6XGMKB*:)NDD;AE/XBO =*\/I<Z'&
MQ\'ZK>2S)N6]ANMHYZ%5QC'US6K\/=+\4Z%XDC6;3;R'3[A62Y#KA!\I(;Z@
M@<^YJ9X6"3Y9:KO8<,5-M7CHSUF/Q1H%P^R#6].F?!.V.Z0G &2>#V'-%KXI
MT&^NA;6NLV,TY.%C2=26/MSS^%?.7A;28=>\0:?I<\_D1W#8:08S@*3@9[G&
M!]>];WQ!\(67A.]L5L;F65;A&8QS$%T*D<Y '!S^GY:/!Q4U3YM62L9-Q<N7
M1'N]_K.EZ6T:ZAJ5I:-("4$\ZQE@.N,D9JK-XK\/VT<<DNM6"I*-R$W"_,.F
M1SR.#7AOBO4;G5/"_A.[O)#),8;F-G/5MD@0$GN< ?C6YX;^'.F:WX+.LS:C
M+'<NLC+L*B.+:2 &&,GID\CK^-1]5C&"E-];%?6Y2ERQCTN>SV=_:W]N+BSN
M8;B)NCPN'7\Q5+4/$NAZ5*8K_5K.WD'6-YE##\.M>'?#/69M+\3"$7)ALKB"
M4W&[[J!(V</CU&W\B:J6T.B7NM;=/TO6M;=BSLDDRQM)ZL=JDXR>N11]449M
M-Z(7UQN":6I[M:^,/#M[,(;?6K%Y&.%3SE!8^P/6KE]K>EZ6R)J&HVEJS@E%
MGG6,L!Z9/-?.7BFP%C?QI_8,FCB2//V:2Y\[=S][/4=",>U:WC2>2YT#PC+,
MY>0V!!9CDG! Y_*J^IIN-GHR5C96E=:H]U37=)E>VCCU.T=[K/V=5F4F7K]W
M!YZ'IZ5#J/B;1-)F$-_JEK;RG'[N24!L'N1U%>2^$O!UU:Z/!XU%\A-K#+/%
M:^46+!5< %MW'/.,5SW@[1(_%_BDVNIWDJF1'GD<,/,F;(X!/?DGZ U*PL/>
M?-HMRWBJEHKEU9WWCSXB7^CZG9IH=Q93V<]OYGF;?,!;<1P0<=JO:IXTU:S\
M.^'KZ+[/YU_;&6;=&2-P"=!GC[QKS3QUX;L_"_B!;&SG>6%X5EVR$%D))&"1
M],UU.N_\B;X._P"O%OY1T5Z4(T8N(8:I.5:2D=/X1\;WVJZVMCJ)@"RH?*,:
M;?G'..OIFM/QMXHN/#\-K%9>4;J9BQWC< @]N.I(_(UYP;>;2[+1M:MR0TC.
M<^CQN?YC'ZUIWEP?&7C"290XM8X68 _PQHN?U8X_X%7&=YM^&/&VKZMXCM;*
M[-L()-Y?;'@\(QZY]J[FWUK2[J=8+;4[.:5L[8XYU9CWX /I7D/@?_D;+/\
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A X"X\ 7$WB1]5&H1!&NQ<>7Y9SC?NQG/MBN]S3J* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>adtx-20211201.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaeMOaPtyJ1xOYkxuG98fRlavyAlbeFfpCvW67I20SYO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:ADTX="http://aditxt.com/20211201" elementFormDefault="qualified" targetNamespace="http://aditxt.com/20211201">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://aditxt.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="adtx-20211201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="adtx-20211201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>adtx-20211201_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>adtx-20211201_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://aditxt.com/role/Cover" xlink:href="adtx-20211201.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://aditxt.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>ea151838-8k_aditxtinc_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adtx-20211201.xsd" xlink:type="simple"/>
    <context id="From2021-12-01to2021-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001726711</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-12-01to2021-12-01">0001726711</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-12-01to2021-12-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-12-01to2021-12-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-12-01to2021-12-01">2021-12-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-12-01to2021-12-01">Aditxt, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-12-01to2021-12-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-12-01to2021-12-01">001-39336</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-12-01to2021-12-01">82-3204328</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-12-01to2021-12-01">737 N. Fifth Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-12-01to2021-12-01">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-12-01to2021-12-01">Richmond</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-12-01to2021-12-01">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-12-01to2021-12-01">23219</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-12-01to2021-12-01">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-12-01to2021-12-01">870-1200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-12-01to2021-12-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-12-01to2021-12-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-12-01to2021-12-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-12-01to2021-12-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-12-01to2021-12-01">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-12-01to2021-12-01">ADTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-12-01to2021-12-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-12-01to2021-12-01">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-12-01to2021-12-01">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139629967026360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  01,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aditxt, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001726711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3204328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">737 N. Fifth Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">870-1200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADTX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M 0  (@(   \   !X;"]W;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( #8UAU,'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ -C6'4UBPY-?N    *P(  !$
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M;',O+G)E;'-02P$"% ,4    "  V-8=3JL0B%C,!   B @  #P
M    @ %S$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ -C6'4R0>FZ*M
M    ^ $  !H              ( !TQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ -C6'4V60>9(9 0  SP,  !,
M ( !N!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @   A0
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea151838-8k_aditxtinc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aditxt.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea151838-8k_aditxtinc.htm">ea151838-8k_aditxtinc.htm</File>
    <File>adtx-20211201.xsd</File>
    <File>adtx-20211201_lab.xml</File>
    <File>adtx-20211201_pre.xml</File>
    <File>ea151838ex1-1_aditxtinc.htm</File>
    <File>ea151838ex5-1_aditxtinc.htm</File>
    <File>ea151838ex99-1_aditxtinc.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea151838-8k_aditxtinc.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea151838-8k_aditxtinc.htm"
     ]
    },
    "labelLink": {
     "local": [
      "adtx-20211201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adtx-20211201_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "adtx-20211201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ADTX",
   "nsuri": "http://aditxt.com/20211201",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea151838-8k_aditxtinc.htm",
      "contextRef": "From2021-12-01to2021-12-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://aditxt.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea151838-8k_aditxtinc.htm",
      "contextRef": "From2021-12-01to2021-12-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://aditxt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-21-063775-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-21-063775-xbrl.zip
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MI;+VDAH\85)AYK_#!ZHD+(+WG<SY#DHJH=\R*"F@ 2SA)/B-,9\ZVJ'Q3:\
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M[>%L4.D%F;95*S '67BXM+SUP:("U'I&A?C$)%]8W8H[P5\2%L%+9DCN!1C
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M8CMW3"4)" ^;KXX,,@)IK1<6%AM,Z>=MFC"2PA.1H7++@M5BDX6&)" 6;+X
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M5*\ K=0S8F45Z'=5"<IKL?U^>7W3M?PD-^M-\J\53HG<\E]02P,$%     @
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ME(SN;8T!Y\,N"ZA3TIXHC4<4Y]Z:N _\@U*!1YR0Q, /'H;\_<)N:R,7J)=
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MR!(+?I[J[[7?I5@$X#5I)*H60A@\6 MXV>''HX>FKY[X-Y<7#JT,8C42,^/
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MF _PK4#;99VP-,E9*C ;DB)P%-"N9E>'Z!=V_X!R_06RBJOM2*HK;[(K9GR
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MAK@&U$6V(*W.]6JUN+F42\X:>I:[#V>&I3"IE,IV]AA=@TH?P,%,0-"#:C@
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M*ORQ&7%U._X\ZJFD?K*74R42^]P=$Z?C&.]%BL#W*K#' *N2,6M[AZ4-PS=
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ME4I/X)Y:>;#*A2U%)@.7^(]E^W"B$TPAOL#(JTI"[!C6H]AO/7I+;X>6AFM
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M"NCJPNS9YMP_<D )\8AB L+^P/T!58FD;]#%/XJ9IY-8=[L!3[20A $@/5'
M'$+_^,WB3_++H"Z"*QI#(*1 @D3:##:]8_;8UJD#7JGL%$R(G\@]IL46U+O]
M)2NT03>](K6"TK<Z)8J,Z;"6F,_5'8*:D!"FJ06X2#[T<?\N 9)1YP=)2_A
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MNPA<H$"])QL8B*4 B,X"S_K5]>'E_JLRC>)\X( 2L#I04>ZU%-\K#3?#83.
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M,F/686]K+Q-"PL, ('3AQ :U+9AMA"7;!%/$^^K"ER4GI-5.6"L9:96.)"!
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MU8")"O&FA3HPM V2BF*(3/2JHH@LFB=EY64^U9.)>(E/[E@=UH,^^(&2X>=
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M2P$"% ,4    "  V-8=3:$XA,"X#  #G"P  $0              @ $
M861T>"TR,#(Q,3(P,2YX<V102P$"% ,4    "  V-8=38O<%+OT*  " A@
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M=&EN8RYH=&U02P$"% ,4    "  V-8=3F%DHOE0*  !:'P  '
M    @ $/SP  96$Q-3$X,SAE>#DY+3%?861I='AT:6YC+FAT;5!+!08
..!P ' .@!  "=V0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
